Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1050.Time spend outdoors in summer,48951,0.0248547121927869,0.0276204325832752,-0.0292813356704326,0.0789907600560063,0.368199948454115
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1060.Time spent outdoors in winter,45231,-0.0259123923332881,0.0314156747509012,-0.0874871148450546,0.0356623301784783,0.409481171746497
CD300E,CMRF35-like molecule 2,Physical activities,X1070.Time spent watching television (TV),50526,0.233012359953665,0.0282416200210756,0.177658784712357,0.288365935194973,1.64862479924028e-16
CD300E,CMRF35-like molecule 2,Physical activities,X1080.Time spent using computer,45230,-0.0875740868467233,0.0292130033409298,-0.144831573394946,-0.0303166002985008,0.00272277591214341
CD300E,CMRF35-like molecule 2,Physical activities,X1090.Time spent driving,42612,-0.138343554485451,0.0321887580225081,-0.201433520209567,-0.0752535887613349,1.73334020711544e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1160.Sleep duration,52064,0.0628092743658305,0.0252530471651304,0.0133133019221749,0.112305246809486,0.0128813070547085
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34131,-0.000662903895791155,0.0143333718989849,-0.0287563128178015,0.0274305050262192,0.963112754312015
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34131,0.00573215814817823,0.0128791290190791,-0.0195109347292168,0.0309752510255732,0.656276641160227
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34131,0.0284651383416497,0.0153824425059627,-0.00168444897003714,0.0586147256533365,0.0642726390026014
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34131,0.0311056838588885,0.0156930528823693,0.000347300209444731,0.0618640675083323,0.0474928367130313
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34131,0.0279851572919946,0.0159015719975142,-0.00318192382313327,0.0591522384071225,0.0784565532141029
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34131,0.0275851648729862,0.0305528871814402,-0.0322984940026366,0.087468823748609,0.366619453782622
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34131,0.0422563873481126,0.0305379672528643,-0.0175980284675014,0.102110803163727,0.166472191027367
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34131,0.00389006652817195,0.0233337462474067,-0.0418440761167452,0.0496242091730891,0.867598424860915
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34131,0.0357936697961339,0.0167328179996246,0.00299734651686971,0.0685899930753981,0.0324501026332389
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34131,0.0162692450612746,0.0115614214368394,-0.00639114095493053,0.0389296310774798,0.159399873360071
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34131,0.0329314915911237,0.0161003208057189,0.00137486281191465,0.0644881203703327,0.0408430576429023
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34131,0.00559809637900728,0.0098634942938777,-0.013734352436993,0.0249305451950076,0.570348896604281
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34131,0.00847687261926227,0.0123036073191384,-0.0156381977262489,0.0325919429647735,0.490855782375198
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34131,0.00612549354964043,0.0176020032576898,-0.0283744328354316,0.0406254199347124,0.727847904231718
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34131,0.019756196164116,0.0167822119045622,-0.013136939168826,0.052649331497058,0.239140443371644
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34131,0.0380151407491911,0.0236010187171223,-0.00824285593636856,0.0842731374347507,0.107268679897565
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34131,0.0189437161327415,0.0217670522107244,-0.0237197062002783,0.0616071384657613,0.384161811848387
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34131,0.0249041922316215,0.0131327066295047,-0.000835912762207652,0.0506442972254507,0.0579436891920825
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34131,0.0138353893997642,0.0122646047642645,-0.0102032359381941,0.0378740147377225,0.259316366620033
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34131,0.0474518008562903,0.016379551075401,0.0153478807485044,0.0795557209640762,0.00377576530851322
CD300E,CMRF35-like molecule 2,Health and medical history,X120040.Fatigue severity over the past week,34137,0.148329250259766,0.0454954971338631,0.0591580758773938,0.237500424642137,0.00111676550106514
CD300E,CMRF35-like molecule 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34134,0.13546634735073,0.0452885490531213,0.0467007912066122,0.224231903494848,0.00278598526643715
CD300E,CMRF35-like molecule 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34134,0.161508728015577,0.0484925177043332,0.0664633933150841,0.25655406271607,0.000869860937502998
CD300E,CMRF35-like molecule 2,Health and medical history,X120098.Mobility problems today,34141,0.309405501437322,0.0536221064875281,0.204306172721767,0.414504830152877,8.16516024114859e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X120099.Self-care problems today,34141,0.241830205342158,0.0836221808768877,0.0779307308234586,0.405729679860858,0.00383725044694924
CD300E,CMRF35-like molecule 2,Health and medical history,X120100.Problems doing usual activities,34141,0.277573336203404,0.0506802951683926,0.178239957673354,0.376906714733453,4.43547102197957e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X120101.Pain or discomfort today,34141,0.145623855142752,0.0457464825546346,0.0559607493356679,0.235286960949836,0.001460772956669
CD300E,CMRF35-like molecule 2,Health and medical history,X120102.Anxiety or depression today,34141,0.0140135237154029,0.0534576299245145,-0.0907634309366456,0.118790478367451,0.793217055963604
CD300E,CMRF35-like molecule 2,Health and medical history,X120103.Scale to indicate how health is today,34101,-0.0181848140717863,0.00425565085347943,-0.0265258897446059,-0.00984373839896657,1.94626262164508e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34116,0.120298280694823,0.0547906581374314,0.0129085907454572,0.227687970644188,0.0281443932589793
CD300E,CMRF35-like molecule 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34093,-0.0241788405056045,0.0553585706461726,-0.132681638972103,0.0843239579608938,0.662289544848603
CD300E,CMRF35-like molecule 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34123,0.077220686495213,0.0447723959549608,-0.01053320957651,0.164974582566936,0.0846065209675461
CD300E,CMRF35-like molecule 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34118,0.152070339252734,0.0462021882535985,0.0615140502756808,0.242626628229787,0.00100044018578136
CD300E,CMRF35-like molecule 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34126,0.166102726035965,0.0558524142951394,0.056631994017492,0.275573458054438,0.00294710937328746
CD300E,CMRF35-like molecule 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34095,0.06243912080152,0.0578155650591861,-0.0508793867144849,0.175757628317525,0.280182208730081
CD300E,CMRF35-like molecule 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34121,0.110147974284738,0.0597393745807125,-0.00694119989345829,0.227237148462935,0.065241619777421
CD300E,CMRF35-like molecule 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34112,0.264607289772204,0.0860953424200029,0.0958604186289982,0.433354160915409,0.00212209091246525
CD300E,CMRF35-like molecule 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34075,0.068851094995488,0.116880836323922,-0.1602353441994,0.297937534190376,0.555827569379722
CD300E,CMRF35-like molecule 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31740,0.218462678629595,0.0590660226492407,0.102693274237083,0.334232083022107,0.000218370954671659
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49704,0.191209866681053,0.0592916663202413,0.0749982006933802,0.307421532668726,0.00126175671620176
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47841,0.0260040223667043,0.0396758708236336,-0.0517606844476176,0.103768729181026,0.512209289995316
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1289.Cooked vegetable intake,51526,-0.182703105376821,0.0262632832174321,-0.234179140482988,-0.131227070270654,3.56514780721182e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51012,-0.133196756378497,0.0283351582251635,-0.188733666499817,-0.0776598462571761,2.60495898584897e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1309.Fresh fruit intake,51561,-0.115129712719726,0.0273085207754495,-0.168654413439607,-0.0616050119998453,2.49601091716912e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1319.Dried fruit intake,49809,-0.183734422632022,0.0275849178631895,-0.237800861643874,-0.129667983620171,2.78131252162745e-11
CD300E,CMRF35-like molecule 2,Health and medical history,X134.Number of self-reported cancers,52349,0.13651805860277,0.0441882391058742,0.0499091099552569,0.223127007250284,0.00200713855961381
CD300E,CMRF35-like molecule 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52349,0.300686202718221,0.0264971914516583,0.248751707472971,0.352620697963472,8.83474475523194e-30
CD300E,CMRF35-like molecule 2,Health and medical history,"X136.Number of operations, self-reported",52349,0.153337156737568,0.0266144714020095,0.101172792789629,0.205501520685507,8.42855703524398e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X137.Number of treatments or medications taken,52349,0.287432725798472,0.0260151038075742,0.236443122335626,0.338422329261317,2.54682698976032e-28
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1438.Bread intake,51393,0.0153250723558266,0.00292811632804657,0.0095859643528553,0.0210641803587978,1.67335233152233e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1458.Cereal intake,50946,0.136352617804104,0.0260864427561148,0.0852231900021194,0.187482045606089,1.73631474035243e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1488.Tea intake,51418,0.0132615207250247,0.00272631337700652,0.00791794650609188,0.0186050949439574,1.15528104831378e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1498.Coffee intake,50144,-0.247352240447703,0.0263831845353531,-0.299063282136995,-0.195641198758411,7.44262364959893e-21
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1528.Water intake,50595,-0.0990465513453159,0.0267786569621542,-0.151532718991138,-0.0465603836994937,0.000217139505071087
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1568.Average weekly red wine intake,41499,-0.249104557186833,0.0329252191276938,-0.313637986677113,-0.184571127696554,4.05191873451567e-14
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41500,-0.187266314491655,0.0330705242033756,-0.252084541930271,-0.122448087053038,1.51468231171384e-08
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,41525,0.0542894038387625,0.0418106033025546,-0.0276593786342446,0.13623818631177,0.194146787589718
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1598.Average weekly spirits intake,41454,0.0550452915355582,0.0367058277845076,-0.0168981309220766,0.126988713993193,0.133727915680877
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1608.Average weekly fortified wine intake,41533,-0.0636856876847698,0.0558263646870805,-0.173105362471448,0.0457339871019079,0.253976828983188
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1737.Childhood sunburn occasions,45707,-0.116218362169931,0.0316864556193161,-0.178323815183791,-0.0541129091560717,0.000245280239235426
CD300E,CMRF35-like molecule 2,Health and medical history,X1807.Father's age at death,44799,-0.00852093007269554,0.00319237765003329,-0.0147779902667608,-0.00226386987863028,0.00761041537700582
CD300E,CMRF35-like molecule 2,Health and medical history,X1845.Mother's age,35342,-0.016423045141223,0.00698163642986078,-0.0301070525437501,-0.00273903773869588,0.0186744024038211
CD300E,CMRF35-like molecule 2,Health and medical history,X1873.Number of full brothers,51831,0.0185743768318607,0.0251989356923093,-0.0308155371250655,0.067964290788787,0.461062032144785
CD300E,CMRF35-like molecule 2,Health and medical history,X1883.Number of full sisters,51838,0.0398605188831352,0.0252667941580391,-0.00966239766662138,0.0893834354328917,0.114672499970691
CD300E,CMRF35-like molecule 2,Physical measures,X20015.Sitting height,52155,0.00172510102254536,0.00361209017753305,-0.00535459572541942,0.00880479777051013,0.63294525115491
CD300E,CMRF35-like molecule 2,Cognitive function,X20016.Fluid intelligence score,33396,-0.149616461272814,0.04220714407322,-0.232342463656325,-0.0668904588893029,0.000394900149725332
CD300E,CMRF35-like molecule 2,Cognitive function,X20018.Prospective memory result,33736,0.0518571440990406,0.0549910663523591,-0.0559253459515833,0.159639634149664,0.345700155599804
CD300E,CMRF35-like molecule 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33263,0.0107723483673554,0.00497023895928113,0.00103068000716434,0.0205140167275464,0.0302333265636336
CD300E,CMRF35-like molecule 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33239,0.0115140791924276,0.00493708208032163,0.00183739831499719,0.021190760069858,0.019714599676811
CD300E,CMRF35-like molecule 2,Cognitive function,X20023.Mean time to correctly identify matches,52037,0.0191220062264494,0.00295383466997408,0.0133324902733002,0.0249115221795986,9.72883529657051e-11
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49099,0.0146372186698785,0.00600667221396115,0.0028641411305147,0.0264102962092424,0.0148238092562277
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48666,-0.0235341944022031,0.0130605931950577,-0.0491329570645162,0.00206456826010992,0.0715698195974005
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48636,-0.00671892777847022,0.0177077600327171,-0.0414261374425957,0.0279882818856552,0.704368872656189
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48652,-0.0085316960336321,0.014325088623792,-0.0366088697362644,0.0195454776690002,0.55146328787914
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48655,0.00701637747872181,0.010737889784528,-0.0140298864989532,0.0280626414563968,0.513490223170574
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48824,-0.00444242184867113,0.0077937100644575,-0.0197180935750078,0.0108332498776656,0.568682333218634
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48755,0.00342015411956182,0.00980172803950604,-0.01579123283787,0.0226315410769937,0.727142039236893
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48664,-0.0188354218584626,0.012534657704846,-0.0434033509599608,0.00573250724303549,0.132937867903525
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48816,0.0272422882353944,0.00883718650071115,0.00992140269400058,0.0445631737767883,0.00205369218030443
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48872,-0.00230613293895591,0.0066685331402624,-0.0153764578938702,0.0107641920159584,0.729478627494581
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48742,0.0102645183913124,0.00930165235586482,-0.00796672022618266,0.0284957570088074,0.269814257151386
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50488,0.017130985246044,0.00671596594076165,0.00396769200215117,0.0302942784899368,0.0107537305424974
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50352,-0.0176523348202979,0.00978299909266906,-0.0368270130419293,0.00152234340133345,0.0711819762518055
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50285,0.0080906787108676,0.020916200507117,-0.0329050742830817,0.0490864317048169,0.698897114893766
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50323,0.00681002553826452,0.0105323218445844,-0.0138333252771208,0.0274533763536499,0.517907274573223
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50416,0.0151237413236334,0.00772511934226437,-1.74925872047458e-05,0.0302649752344716,0.0502717383296726
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50309,0.00333033557712636,0.0142752862711302,-0.0246492255142889,0.0313098966685416,0.815535130450167
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50304,-0.0179924159975141,0.0126667954908525,-0.0428193351595851,0.00683450316455683,0.155491845155379
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50332,-0.0112681945609925,0.0100427551142204,-0.0309519945848644,0.00841560546287948,0.261863394914717
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50350,0.0609208443267851,0.0112386701049075,0.0388930509211665,0.0829486377324038,5.99144158146355e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50514,-0.00169375226215887,0.0058290143575419,-0.013118620402941,0.00973111587862325,0.771380477210592
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50364,0.0139893298351968,0.00918634502669958,-0.00401590641713432,0.031994566087528,0.127811047140112
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46847,0.0223658857922351,0.00948598319978461,0.00377335872065727,0.0409584128638129,0.0183930077145677
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46702,0.0497764519442683,0.0372592099754381,-0.0232515996075904,0.122804503496127,0.181579189210642
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46699,0.00730979686014609,0.0383430335019701,-0.0678425488037153,0.0824621425240075,0.848807734730828
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46763,0.00705357987500584,0.0104692572764481,-0.0134661643868325,0.0275733241368441,0.500482240838495
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46714,0.0485171621615251,0.0221448924066299,0.00511317304453061,0.0919211512785196,0.0284696291735182
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46727,0.0192697772342606,0.0161352311638053,-0.0123552758467978,0.050894830315319,0.232386183429037
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46708,0.0391955928346611,0.0196259870409353,0.000728658234427908,0.0776625274348943,0.0458235193791424
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46707,-0.00376862713641502,0.0190393915981035,-0.0410858346686979,0.0335485803958679,0.843095049987428
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46726,0.00603944733324701,0.0139202843859931,-0.0212443100632995,0.0333232047297935,0.664394688370797
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46728,0.0261822512099562,0.0168249975891025,-0.00679474406468472,0.059159246484597,0.119686192873461
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46919,0.00394716508241841,0.00699598416025981,-0.00976496387169082,0.0176592940365276,0.572620662183273
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46800,0.0271507890164617,0.0100554408167184,0.0074421250156937,0.0468594530172297,0.00693688899233918
CD300E,CMRF35-like molecule 2,Mental health,X20127.Neuroticism score,46365,0.114561251353655,0.0266094541235335,0.0624067212715295,0.166715781435781,1.67496240210944e-05
CD300E,CMRF35-like molecule 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33396,-0.0458698822865511,0.0430613525048757,-0.130270133196107,0.0385303686230054,0.286804457289824
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20161.Pack years of smoking,31881,0.0348880027441684,0.00593500384088095,0.0232553952160417,0.0465206102722951,4.32311542685069e-09
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31881,0.0339067815738732,0.00585606829979099,0.0224288877062829,0.0453846754414636,7.32426633233303e-09
CD300E,CMRF35-like molecule 2,Cognitive function,X20191.Fluid intelligence score,31530,-0.00532128247793188,0.0487804121389235,-0.100930890270222,0.0902883253143581,0.913137011729008
CD300E,CMRF35-like molecule 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31530,-0.0153044917550753,0.0499703419268395,-0.113246361931681,0.0826373784215302,0.759406957723482
CD300E,CMRF35-like molecule 2,Cognitive function,X20240.Maximum digits remembered correctly,30775,-0.107640003036153,0.0525129031308162,-0.210565293172553,-0.00471471289975339,0.0404269221552966
CD300E,CMRF35-like molecule 2,Physical measures,X20255.Spirometry QC measure,45925,-0.0367407015337921,0.0356428514124048,-0.106600690302105,0.0331192872345212,0.30264556529211
CD300E,CMRF35-like molecule 2,Eye measures,X20261.avMSE,30497,0.00869897848428427,0.00562172676411036,-0.00231960597337204,0.0197175629419406,0.121822662842158
CD300E,CMRF35-like molecule 2,Eye measures,X20262.Myopia diagnosis,30497,-0.0866876553152602,0.0653305708080762,-0.214735574099089,0.0413602634685692,0.184589252899645
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20280.Glucose-lactate,40391,-0.00689318995038567,0.00379844888243278,-0.0143381497599539,0.000551769859182576,0.0695829540843719
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40429,-0.0158823013063272,0.00363225043759812,-0.0230015121640195,-0.00876309044863484,1.2356377715288e-05
CD300E,CMRF35-like molecule 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33209,-0.0388751928345107,0.0175554928818702,-0.0732839588829762,-0.00446642678604517,0.0268257171488646
CD300E,CMRF35-like molecule 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33206,-0.00370566149814896,0.033106552768465,-0.0685945049243404,0.0611831819280425,0.910880396921337
CD300E,CMRF35-like molecule 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33204,-0.0683116398315806,0.0407521865109745,-0.148185925393091,0.0115626457299294,0.0937211685296718
CD300E,CMRF35-like molecule 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33204,-0.0400727071462922,0.0164809849493367,-0.0723754376469921,-0.0077699766455924,0.0150584159788958
CD300E,CMRF35-like molecule 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33204,-0.0896856934765038,0.0327253698073509,-0.153827418298912,-0.025543968654096,0.00614598266489077
CD300E,CMRF35-like molecule 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33211,-0.0266117544528237,0.0398181957985208,-0.104655418217925,0.0514319093122772,0.503939622440035
CD300E,CMRF35-like molecule 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33211,-0.0141044073201747,0.0264648057893032,-0.065975426667209,0.0377666120268596,0.594081998909943
CD300E,CMRF35-like molecule 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33211,0.0167926692150049,0.0293076988510008,-0.0406504205329566,0.0742357589629665,0.566674239535937
CD300E,CMRF35-like molecule 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33211,0.0161881759362202,0.047806227687631,-0.0775120303315364,0.109888382203977,0.734903640267369
CD300E,CMRF35-like molecule 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33211,-0.03377158466524,0.0578435323393321,-0.147144908050331,0.0796017387198509,0.559340476775458
CD300E,CMRF35-like molecule 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33211,0.031934865871265,0.030493939062995,-0.0278332546922052,0.0917029864347352,0.295011853774046
CD300E,CMRF35-like molecule 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33211,0.088440628078914,0.0578600855846496,-0.0249651396669992,0.201846395824827,0.126418176356831
CD300E,CMRF35-like molecule 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33211,-0.0116840998058012,0.0400923044443605,-0.0902650165167477,0.0668968169051453,0.770729383248767
CD300E,CMRF35-like molecule 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33211,-0.0785270453963686,0.0470444147742482,-0.170734098353895,0.0136800075611579,0.0951113464613162
CD300E,CMRF35-like molecule 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33211,-0.0229771749804788,0.0222443495437682,-0.0665761000862644,0.0206217501253069,0.301658465550226
CD300E,CMRF35-like molecule 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33211,-0.0847731296582426,0.0360512680810107,-0.155433615097024,-0.0141126442194617,0.0187219102369412
CD300E,CMRF35-like molecule 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33212,-0.00241409178317938,0.0534281950128601,-0.107133354008385,0.102305170442026,0.963961793346564
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20600.Liking for adding salt to foods,35077,-0.0492274379198427,0.0400890132916627,-0.127801903971502,0.0293470281318163,0.219491707711517
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20601.Liking for aniseed,35077,-0.0581832714487638,0.0399728544702691,-0.136530066210491,0.0201635233129636,0.145541209087004
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20602.Liking for apple juice,35077,0.165045210537576,0.0403272233115036,0.0860038528470289,0.244086568228123,4.29626947558925e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20603.Liking for apples,35077,-0.0546730124672411,0.0410557507256737,-0.135142283889561,0.0257962589550794,0.18299483338944
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20604.Liking for asparagus,35077,-0.161063075373688,0.0413018500817724,-0.242014701533961,-0.0801114492134137,9.69222152694451e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20605.Liking for aubergine,35077,-0.211280915285863,0.0403756430446894,-0.290417175653454,-0.132144654918271,1.70072420785836e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20606.Liking for avocados,35077,-0.290398361346897,0.0414176597941552,-0.371576974543441,-0.209219748150353,2.50180233692335e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20607.Liking for bacon,35077,-0.0859159286326736,0.0405300260852071,-0.16535477975968,-0.00647707750566759,0.0340452641228223
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35077,-0.189987526971965,0.0412362606474437,-0.270810597840954,-0.109164456102975,4.1269633221068e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20609.Liking for bananas,35077,0.158700220832202,0.0421818111167486,0.0760238710433751,0.24137657062103,0.000169270224938934
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35077,-0.178154299433702,0.0403738990645842,-0.257287141600287,-0.0990214572671173,1.03139092528034e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20611.Liking for beef steak,35077,-0.174443334511054,0.0402414051180704,-0.253316488542472,-0.0955701804796364,1.47155928116509e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20612.Liking for beetroot,35077,-0.0171812480591749,0.0411922921805003,-0.0979181407329554,0.0635556446146057,0.676614711161813
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20613.Liking for bell pepper,35077,-0.149689623999905,0.0405585907317231,-0.229184461834082,-0.0701947861657277,0.000224756271313432
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20614.Liking for bicycling,35077,-0.0814624287743691,0.0403852113079222,-0.160617442937897,-0.00230741461084147,0.0437065342396483
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20615.Liking for biscuits,35077,0.182689951257879,0.0402391474799559,0.103821222197165,0.261558680318593,5.6845058625321e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20616.Liking for bitter foods,35077,-0.2488642991083,0.0402518471258339,-0.327757919474934,-0.169970678741666,6.53393212108838e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20617.Liking for bitter or ale,35077,-0.164597950026249,0.0421654997838804,-0.247242329602655,-0.0819535704498437,9.5351847447026e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20618.Liking for black olives,35077,-0.255503991522097,0.0406802298212557,-0.335237241971758,-0.175770741072436,3.50040107250886e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20619.Liking for black pepper,35077,-0.147021748275534,0.04085727972597,-0.227102016538435,-0.0669414800126327,0.00032161036590443
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20620.Liking for blue cheese,35077,-0.225060207782675,0.0408201074096541,-0.305067618305597,-0.145052797259753,3.60071355234981e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20621.Liking for bolognese sauce,35077,-0.0569524978578205,0.0406848945884034,-0.136694891251091,0.0227898955354502,0.161589316910129
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20622.Liking for broad beans,35077,-0.160223394916625,0.0404534430025235,-0.23951214320157,-0.0809346466316785,7.52229615685018e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20623.Liking for broccoli,35077,-0.0604554554651179,0.0422503109456722,-0.143266064918635,0.0223551539883996,0.152491801766359
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20624.Liking for brown rice,35077,-0.108407056343192,0.0403674907633736,-0.187527338239404,-0.0292867744469797,0.00725331035543513
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20625.Liking for brussel sprouts,35077,-0.0680136566892812,0.0407077257053088,-0.147800799071686,0.011773485693124,0.0947946038242622
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20626.Liking for burgers (meat),35077,-0.0894245309266919,0.0401768746179742,-0.168171205177921,-0.0106778566754624,0.0260504270382445
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35077,-0.243622595940882,0.0404444895789297,-0.322893795515584,-0.16435139636618,1.76204196824291e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20628.Liking for butter on bread,35077,0.0307133045140608,0.0409167542663208,-0.049483533847928,0.11091014287605,0.45289256796417
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20629.Liking for butternut squash,35077,-0.129957309990756,0.0406546438803846,-0.20964041199631,-0.0502742079852021,0.00139457005248015
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20630.Liking for cabbage,35077,0.00645115842366418,0.0411108063199256,-0.0741260219633899,0.0870283388107183,0.875309909632401
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20631.Liking for cake,35077,0.161631335196645,0.0404412620693075,0.0823664615408029,0.240896208852488,6.46676684269229e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20632.Liking for cake icing,35077,0.181412169202919,0.0401581860296984,0.102702124584711,0.260122213821128,6.32676958117564e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20633.Liking for capers,35077,-0.312644088633404,0.0402382518239664,-0.391511062208378,-0.233777115058429,8.58531110986772e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20634.Liking for cauliflower,35077,0.0258827946335795,0.0412055477663374,-0.0548800789884418,0.106645668255601,0.529926667948821
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35077,0.119053075227283,0.0399939167279565,0.0406649984404878,0.197441152014077,0.00291950490734724
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20636.Liking for cheesecake,35077,0.0546207419855113,0.0401756642323704,-0.0241235599099347,0.133365043880957,0.17400189422002
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20637.Liking for cherries,35077,-0.0670495576186072,0.0437822127729012,-0.152862694653494,0.0187635794162792,0.125692028866983
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20638.Liking for chicken,35077,-0.0250389106515194,0.0427801922213082,-0.108888087405283,0.0588102661022446,0.558363733144037
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20639.Liking for chilli pepper,35077,-0.283275964285597,0.0405318773893996,-0.362718443968821,-0.203833484602374,2.9353814182472e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20640.Liking for chips or french fries,35077,0.0437715272652675,0.0405077133963506,-0.0356235909915797,0.123166645522115,0.279911800452438
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20641.Liking for cigarette smoking,35077,-0.0037834783801224,0.0669448926318145,-0.134995467938479,0.127428511178234,0.954931565497144
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20642.Liking for cod,35077,-0.150562177764985,0.0419302387314149,-0.232745445678558,-0.0683789098514119,0.000331180848763772
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20643.Liking for coffee with sugar,35077,0.167915299155173,0.0455712772584021,0.0785955957287054,0.257235002581641,0.000230134588208477
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20644.Liking for coffee without sugar,35077,-0.233766669777675,0.0412211449358254,-0.314560113851893,-0.152973225703457,1.45644942412696e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20645.Liking for coriander,35077,-0.179124858403283,0.040675864796084,-0.258849553403608,-0.0994001634029583,1.07455115921716e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20646.Liking for corn flakes,35077,0.21899707469821,0.0403709262366957,0.139870059274287,0.298124090122134,5.93520468484342e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20647.Liking for cream,35077,0.00840314062481969,0.040043319875122,-0.0700817663304195,0.0868880475800589,0.833787800830502
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20648.Liking for croissant,35077,0.02374329148171,0.040242980069063,-0.0551329494536535,0.102619532417073,0.555204318969099
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20649.Liking for cucumber,35077,-0.0211791309947235,0.0407770144186357,-0.101102079255249,0.0587438172658024,0.603500358494638
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20650.Liking for curry,35077,-0.165272614087628,0.040726457001394,-0.24509646981036,-0.0854487583648958,4.98250300932822e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20651.Liking for dairy products,35077,0.0627170049162162,0.0409313076914148,-0.0175083581589568,0.142942367991389,0.125490499648863
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20652.Liking for dark chocolate,35077,-0.231207364585632,0.0408322744796107,-0.311238622565669,-0.151176106605595,1.53177105211602e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35077,0.102658715106517,0.0422629879316507,0.0198232587604818,0.185494171452553,0.01515512244673
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20654.Liking for dried fruit,35077,-0.000656310032256376,0.0403331256862628,-0.0797092363773315,0.0783966163128188,0.987017514984945
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20655.Liking for eggs,35077,-0.114660660226831,0.0418441296781979,-0.196675154396099,-0.0326461660575632,0.00615072181518933
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20656.Liking for exercising alone,35077,-0.149762301529079,0.0403527867273733,-0.228853763514731,-0.0706708395434274,0.000207230975389847
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20657.Liking for exercising with others,35077,-0.136515134478168,0.0403995152657047,-0.21569818439895,-0.0573320845573873,0.000729778181739382
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35077,-0.152503997901785,0.0409528058050922,-0.232771497279765,-0.0722364985238041,0.00019718701052668
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20659.Liking for fatty foods,35077,-0.0554871636513954,0.0401911458388702,-0.134261809495581,0.0232874821927902,0.167436654644146
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35077,-0.0256847747159153,0.0445701829128712,-0.113042333225143,0.0616727837933124,0.564440131671653
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20661.Liking for fried chicken,35077,-0.0120651068428437,0.0399485116738954,-0.0903641897236786,0.0662339760379912,0.762645455081587
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20662.Liking for fried or battered fish,35077,-0.0530728452508766,0.0402094242187409,-0.131883316719609,0.0257376262178556,0.186893328411256
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20663.Liking for fruit,35077,-0.0275766366214558,0.0469573121381425,-0.119612968412215,0.0644596951693035,0.55703464789706
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20664.Liking for garlic,35077,-0.166174355746231,0.0409550360752053,-0.246446226453633,-0.0859024850388285,4.99596684973323e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20665.Liking for gherkins,35077,-0.203644020674226,0.0402630023653336,-0.28255950531028,-0.124728536038172,4.31106614558531e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20666.Liking for globe artichoke,35077,-0.215408558906497,0.0403939616052903,-0.294580723652866,-0.136236394160128,9.87547019568399e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20667.Liking for goat's cheese,35077,-0.165201780861563,0.0402113024617817,-0.244015933686656,-0.0863876280364713,4.01501889646905e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20668.Liking for going to a cafe,35077,0.0537379824651859,0.0406762815151078,-0.0259875293044254,0.133463494234797,0.186492014207511
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20669.Liking for going to the gym,35077,-0.153996336115124,0.0402125274507689,-0.232812889918631,-0.0751797823116171,0.000129110336005708
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20670.Liking for going to the pub,35077,-0.119636808023401,0.0405359829877548,-0.1990873346794,-0.0401862813674011,0.00317056314015683
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20671.Liking for grapefruit,35077,-0.125191570107161,0.0402951268182073,-0.204170018670847,-0.0462131215434743,0.00189580776013204
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20672.Liking for green olives,35077,-0.252204990493104,0.0407514840489893,-0.332077899229123,-0.172332081757085,6.28400559684194e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20673.Liking for haddock,35077,-0.181505870898585,0.0416611104729807,-0.263161647425627,-0.099850094371543,1.33265215190383e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20674.Liking for ham,35077,-0.0592457084071639,0.0403524114178712,-0.138336434786191,0.0198450179718636,0.142077526599643
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20675.Liking for hard cheese,35077,-0.0506478086348194,0.0415096743591237,-0.132006770378702,0.030711153109063,0.222437134147699
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20676.Liking for herring,35077,-0.236228390825172,0.0404155808938627,-0.315442929377143,-0.157013852273202,5.2153414602109e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20677.Liking for honey,35077,0.0325105453914714,0.0403320373714137,-0.0465402478564994,0.111561338639442,0.420219113994497
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35077,-0.287185160746468,0.0404878736828118,-0.366541393164779,-0.207828928328156,1.39480662972689e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20679.Liking for ice cream,35077,0.0682646785957662,0.0406707271181348,-0.011449946555778,0.14797930374731,0.0932844150958698
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20680.Liking for jam,35077,0.165196097250933,0.0401834318817251,0.0864365707627518,0.243955623739114,3.96828568782928e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20681.Liking for kiwi fruit,35077,0.0510049478857602,0.0408992210697607,-0.0291575254109709,0.131167421182491,0.212392564432052
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20682.Liking for lager,35077,-0.157106553768558,0.0407685284961726,-0.237012869621057,-0.0772002379160598,0.000117068047382655
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20683.Liking for lamb,35077,-0.161581645658101,0.0403672000541399,-0.240701357764215,-0.0824619335519869,6.30241463045284e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20684.Liking for lemons,35077,-0.196292086951298,0.0405821058240207,-0.275833014366379,-0.116751159536218,1.33724647525727e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20685.Liking for lentils or beans,35077,-0.026593920868918,0.0409491630366803,-0.106854280420811,0.0536664386829755,0.516069701390835
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20686.Liking for liver,35077,-0.216182689501026,0.0406972140070524,-0.295949228954849,-0.136416150047203,1.10635468114746e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20687.Liking for mackerel,35077,-0.209747889857932,0.0403144306739762,-0.288764173978925,-0.130731605736938,1.99970684291117e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20688.Liking for marzipan,35077,0.0154903805692696,0.0401391432993068,-0.0631823402973717,0.0941631014359109,0.699565821403954
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20689.Liking for mayonnaise,35077,-0.0462220095861533,0.0401096934407423,-0.124837008730008,0.0323929895577017,0.249186797679259
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20690.Liking for melon,35077,0.031993860905143,0.0429044994005169,-0.0520989579198702,0.116086679730156,0.455865511659286
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20691.Liking for milk chocolate,35077,0.142921539423748,0.0404624935852119,0.0636150519967327,0.222228026850763,0.000413870114890867
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20692.Liking for mushrooms,35077,-0.069790746395571,0.0417922443262108,-0.151703545274944,0.0121220524838023,0.0949597418038507
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20694.Liking for orange juice,35077,0.0949886694315749,0.040450290727884,0.0157060996049223,0.174271239258228,0.0188785073844361
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20695.Liking for oranges,35077,-0.0618467084208864,0.041230262395199,-0.142658022715476,0.0189646058737036,0.133635879712243
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20696.Liking for pasta,35077,0.047723539188595,0.0406371508707233,-0.0319252765180226,0.127372354895213,0.240268387806904
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20697.Liking for pears,35077,0.066411202607814,0.0413663351800941,-0.0146668143451703,0.147489219560798,0.10842657344528
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20698.Liking for pizza,35077,-0.0061778481753493,0.0404402341486209,-0.0854407071066463,0.0730850107559477,0.878586584731278
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20699.Liking for plain yogurt,35077,-0.135900324368057,0.0408273290689593,-0.215921889343217,-0.0558787593928965,0.000875616265236573
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20700.Liking for plums,35077,0.00635202462430934,0.0416554681878049,-0.0752926930237884,0.087996742272407,0.878803710462213
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20701.Liking for pollock,35077,-0.230619825487709,0.0401480548482444,-0.309310012990268,-0.15192963798515,9.48763617015898e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20702.Liking for pork chop,35077,-0.12378410749303,0.0402042986748477,-0.202584532895732,-0.0449836820903285,0.00208312442262875
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20703.Liking for porridge,35077,0.0464030531987289,0.0415539155615983,-0.0350426213020037,0.127848727699462,0.26414999418763
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20704.Liking for potato crisps,35077,0.0294180057066391,0.0402743386440486,-0.0495196980356961,0.108355709448974,0.465137124668218
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20705.Liking for potatoes,35077,0.132541534783006,0.040740235475962,0.0526906732501208,0.212392396315892,0.00114416493553442
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20706.Liking for prawns,35077,-0.324207464545878,0.0415371054359376,-0.405620191200316,-0.24279473789144,6.49706467055325e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20707.Liking for raw carrots,35077,-0.0424835395564851,0.041193166512816,-0.123222145921605,0.0382550668086343,0.302411966294911
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20708.Liking for red meat,35077,-0.183297235752658,0.0402623390962178,-0.262211420381245,-0.104383051124072,5.35832019908188e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20709.Liking for red wine,35077,-0.257012531058172,0.0405697022327624,-0.336529147434386,-0.177495914681957,2.46816959941524e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35077,0.107313081683957,0.0424473038177526,0.0241163662011615,0.190509797166752,0.0114809652025493
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20711.Liking for roast chicken,35077,-0.0552416906329351,0.0428536266696008,-0.139234798905353,0.0287514176394825,0.19739886969262
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20712.Liking for salad dressing,35077,-0.06325740813992,0.0406070869894458,-0.142847298639234,0.0163324823593938,0.119312296666166
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20713.Liking for salad leaves,35077,-0.0156602115107627,0.0419204665521388,-0.0978243259529548,0.0665039029314294,0.708732021611674
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20714.Liking for salami,35077,-0.287034442001174,0.0403383473656449,-0.366097602837838,-0.20797128116451,1.18556480639122e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20715.Liking for salmon,35077,-0.205930757296975,0.0433270939743104,-0.290851861486623,-0.121009653107327,2.0311996146098e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20716.Liking for salty foods,35077,-0.0745537800349336,0.0398509625562674,-0.152661666645218,0.00355410657535044,0.0613982116656112
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20717.Liking for salty pretzels,35077,-0.0720909197512535,0.0402880243328958,-0.151055447443729,0.00687360794122224,0.0735807970011759
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20718.Liking for sardines,35077,-0.24183038108049,0.0401388640928199,-0.320502554702417,-0.163158207458563,1.74890357167504e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20719.Liking for sausages (meat),35077,-0.0726466290189877,0.0401264014897011,-0.151294375938802,0.00600111790082637,0.0702551201584745
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20720.Liking for savoury biscuits,35077,0.0157088264954246,0.0403384214556451,-0.0633544795576398,0.0947721325484891,0.696968919539941
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35077,-0.324550105769809,0.0406612676247468,-0.404246190314312,-0.244854021225305,1.59090897599606e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20722.Liking for skimmed milk,35077,0.11973789801728,0.0402289016686224,0.0408892507467797,0.19858654528778,0.0029229775127585
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20723.Liking for smoked fish,35077,-0.194900079667169,0.0404545953767134,-0.274191086605528,-0.115609072728811,1.47196051128985e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20724.Liking for soft cheese,35077,-0.113848411564196,0.0406448508277008,-0.19351231918649,-0.0341845039419025,0.00510281767622477
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20725.Liking for soy sauce,35077,-0.140935805549262,0.0403891985956311,-0.220098634796699,-0.061772976301825,0.000485991634996769
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20726.Liking for soya milk,35077,-0.0234934929946953,0.040508217920411,-0.102889600118701,0.0559026141293102,0.561948125263964
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20727.Liking for spicy foods,35077,-0.262265363020932,0.0405294048068471,-0.341702996442352,-0.182827729599511,1.01654378313921e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20728.Liking for spinach,35077,-0.159222302533941,0.0410725031968393,-0.239724408799746,-0.0787201962681365,0.000106557570103284
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20729.Liking for spirits,35077,-0.220460144668785,0.0404804852817464,-0.299801895821008,-0.141118393516562,5.26388899159685e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20730.Liking for strawberries,35077,-0.00364024850451066,0.0461968704801315,-0.0941861146455684,0.0869056176365471,0.937194306461623
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35077,0.16716705280272,0.0419014359680549,0.0850402383053322,0.249293867300108,6.66488510241535e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20732.Liking for sweet foods,35077,0.223047799082911,0.0404709210949813,0.143724793736747,0.302370804429074,3.64494150014399e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20733.Liking for taking the stairs,35077,-0.261526008999611,0.0414009216038047,-0.342671815343068,-0.180380202656154,2.77524596706823e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20734.Liking for tea with sugar,35077,0.217310365539281,0.0532093541229414,0.113020031458316,0.321600699620246,4.45798516640057e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20735.Liking for tea without sugar,35077,0.0146505984933852,0.0431261466783761,-0.0698766489962319,0.0991778459830024,0.734077892430403
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20736.Liking for tomato ketchup,35077,0.0274405191470042,0.0399847015883242,-0.0509294959661112,0.10581053426012,0.492554413952608
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20737.Liking for tinned tuna,35077,-0.0643312654007284,0.0405279936806795,-0.14376613301486,0.0151036022134034,0.112467900119208
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20738.Liking for turnip (white),35077,0.0268157154438372,0.040133729744891,-0.0518463948561492,0.105477825743824,0.504046586725998
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20739.Liking for vegetables,35077,-0.03045386461478,0.0469198861278703,-0.122416841425406,0.0615091121958458,0.516313039250156
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20740.Liking for vinegar,35077,-0.0665264517525805,0.0402199693859683,-0.145357591749078,0.0123046882439173,0.0981438299434178
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20741.Liking for watching television,35077,0.120133024171556,0.0405856357758556,0.0405851780508789,0.199680870292233,0.00308330188379092
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20742.Liking for whisky,35077,-0.169550671046073,0.0433580391240903,-0.25453242772929,-0.0845689143628561,9.26869669639437e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20743.Liking for white bread,35077,0.148400057990095,0.0400108982435692,0.0699786974326997,0.226821418547491,0.000209147836993368
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20744.Liking for white rice,35077,0.0778881482863758,0.0402919572636912,-0.00108408795045901,0.156860384523211,0.0532511563139884
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20745.Liking for white wine,35077,-0.313404401910807,0.0404842789559498,-0.392753588664469,-0.234055215157145,1.07283930434282e-14
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35077,-0.00821278467660224,0.0408135834263375,-0.0882074081922238,0.0717818388390193,0.840525132371167
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20747.Liking for whole milk,35077,0.0312205325986646,0.0403196757367696,-0.0478060318454038,0.110247097042733,0.438755872075096
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20748.Liking for wholemeal bread,35077,0.0704518500775561,0.0427220694679239,-0.0132834060795746,0.154187106234687,0.0991620820568246
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20749.Liking for working up a sweat,35077,-0.158914020783926,0.0404074932211613,-0.238112707497403,-0.0797153340704501,8.45011089399901e-05
CD300E,CMRF35-like molecule 2,Physical measures,X21001.Body mass index (BMI),52247,-0.0110971826988162,0.0104822214715251,-0.0316423367830054,0.0094479713853731,0.289760629706782
CD300E,CMRF35-like molecule 2,Physical measures,X21002.Weight,52255,0.023991257809328,0.00648826061242373,0.0112742670089775,0.0367082486096785,0.000218030787600965
CD300E,CMRF35-like molecule 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33625,0.00939598160177303,0.00459210176490323,0.000395462142562687,0.0183965010609834,0.0407732239304773
CD300E,CMRF35-like molecule 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34487,-0.00291319066867389,0.0425458836478936,-0.0863031226185454,0.0804767412811976,0.945411480642307
CD300E,CMRF35-like molecule 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34502,0.0432279951236886,0.0443949996539231,-0.0437862041980008,0.130242194445378,0.330222426516316
CD300E,CMRF35-like molecule 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34503,-0.00679282422202191,0.0444841295740955,-0.0939817181872491,0.0803960697432052,0.878636195933248
CD300E,CMRF35-like molecule 2,Health and medical history,X21040.Satisfaction with bowel habits,34454,0.0158632441674397,0.0413057680910789,-0.0650960612910749,0.0968225496259543,0.70095379608161
CD300E,CMRF35-like molecule 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34435,0.0470637681401092,0.0429897951024861,-0.0371962302607636,0.131323766540982,0.2736455798959
CD300E,CMRF35-like molecule 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34447,-0.00963287367872291,0.044144554630683,-0.0961562007548616,0.0768904533974158,0.8272683535307
CD300E,CMRF35-like molecule 2,Health and medical history,X21043.Least number of times bowels opened per week,34355,-0.0174644648770154,0.0436013962372481,-0.102923201502022,0.0679942717479909,0.688761361996695
CD300E,CMRF35-like molecule 2,Health and medical history,X21044.Average number of times bowels opened per day,34408,0.0520297352171724,0.0498151898735865,-0.0456080369350571,0.149667507369402,0.296300204518218
CD300E,CMRF35-like molecule 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34506,-0.0386913103060371,0.0449459866343292,-0.126785444109322,0.0494028234972481,0.389346613334571
CD300E,CMRF35-like molecule 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34500,-0.069097998343469,0.0452433656667109,-0.157774995050222,0.0195789983632845,0.126729962118901
CD300E,CMRF35-like molecule 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34503,0.110580140863569,0.0530002765590229,0.0066995988078843,0.214460682919254,0.0369669331467416
CD300E,CMRF35-like molecule 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34503,-0.0151700690474871,0.0468528686797275,-0.107001691659753,0.0766615535647789,0.746110573153939
CD300E,CMRF35-like molecule 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34500,-0.121937155451112,0.0690479039133985,-0.257271047121373,0.013396736219149,0.0774297199120915
CD300E,CMRF35-like molecule 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34501,-0.0500458055137302,0.0513288425062972,-0.150650336826073,0.0505587257986123,0.329581952811344
CD300E,CMRF35-like molecule 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34501,-0.252763546113853,0.125916730189447,-0.499560337285169,-0.00596675494253662,0.0447352518162645
CD300E,CMRF35-like molecule 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34505,-0.00722502756440745,0.0486690575398101,-0.102616380342435,0.0881663252136203,0.881988902345144
CD300E,CMRF35-like molecule 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34504,-0.237206532757215,0.0510809283850536,-0.33732515239192,-0.13708791312251,3.46498380066382e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34237,0.113252440666335,0.0458552670354666,0.0233761172768206,0.20312876405585,0.0135365387653898
CD300E,CMRF35-like molecule 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34501,-0.0428886773576337,0.0459710484609367,-0.13299193234107,0.0472145776258024,0.350868339981586
CD300E,CMRF35-like molecule 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34503,-0.0802467849984541,0.0602997422753072,-0.198434279858056,0.0379407098611481,0.183285630738672
CD300E,CMRF35-like molecule 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34505,-0.191820152729629,0.0448512471333953,-0.279728597111084,-0.103911708348175,1.91345355811973e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34503,0.056143755188994,0.0448454981628627,-0.0317534212102169,0.144040931588205,0.210621820628427
CD300E,CMRF35-like molecule 2,Working and living environment,X21100.Water hardness (USGS classification),52111,-0.0627672900775129,0.0254841747158837,-0.112716272520645,-0.0128183076343809,0.0137843879747602
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2139.Age first had sexual intercourse,48417,0.000390477835619027,0.00328233110321273,-0.00604289112667793,0.00682384679791598,0.905305212479182
CD300E,CMRF35-like molecule 2,Health and medical history,X2149.Lifetime number of sexual partners,46890,-0.1159641638102,0.0290896962590805,-0.172979968477998,-0.058948359142402,6.72859218799695e-05
CD300E,CMRF35-like molecule 2,Physical activities,X22032.IPAQ activity group,45965,-0.251985019313633,0.0292415883329413,-0.309298532446198,-0.194671506181068,7.317043163054e-18
CD300E,CMRF35-like molecule 2,Physical activities,X22033.Summed days activity,46652,-0.0302301439606805,0.00310786894375391,-0.0363215670904382,-0.0241387208309229,2.56396204456132e-22
CD300E,CMRF35-like molecule 2,Physical activities,X22034.Summed minutes activity,45965,-0.0231436358493212,0.0031285932998896,-0.0292756787171048,-0.0170115929815376,1.43905178137605e-13
CD300E,CMRF35-like molecule 2,Physical activities,X22037.MET minutes per week for walking,44917,-0.014007484992759,0.00316952591978455,-0.0202197557955367,-0.00779521418998131,9.94719735670733e-06
CD300E,CMRF35-like molecule 2,Physical activities,X22038.MET minutes per week for moderate activity,45965,-0.0177668872028908,0.00308944005859745,-0.0238221897177418,-0.0117115846880398,9.00021127109445e-09
CD300E,CMRF35-like molecule 2,Physical activities,X22039.MET minutes per week for vigorous activity,45965,-0.297006223327326,0.0294736853285254,-0.354774646571236,-0.239237800083417,7.88729589841114e-24
CD300E,CMRF35-like molecule 2,Physical activities,X22040.Summed MET minutes per week for all activity,44917,-0.0256065243565679,0.00322465664660425,-0.0319268513839122,-0.0192861973292235,2.11090794919116e-15
CD300E,CMRF35-like molecule 2,Eye measures,X2217.Age started wearing glasses or contact lenses,48443,-0.00582636839920955,0.0029933608317136,-0.0116933556293682,4.06188309491047e-05,0.0516147231604814
CD300E,CMRF35-like molecule 2,Working and living environment,X22501.Year ended full time education,31385,-0.0486549714582447,0.0135640716647409,-0.0752405519211368,-0.0220693909953526,0.000336748018395554
CD300E,CMRF35-like molecule 2,Lifestyle factors,X22506.Tobacco smoking,31341,-0.0495229933199703,0.111074780175632,-0.267229562464209,0.168183575824268,0.655717649228832
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50450,-0.283717245025057,0.0631187832710093,-0.407430060236236,-0.160004429813879,6.98788858433742e-06
CD300E,CMRF35-like molecule 2,Physical measures,X23098.Weight,51825,0.0252962738896039,0.00650824540412981,0.0125401128975095,0.0380524348816983,0.000101812074227669
CD300E,CMRF35-like molecule 2,Physical measures,X23099.Body fat percentage,51826,0.0781677727577935,0.00665637989300695,0.0651212681674999,0.0912142773480871,9.11343421311537e-32
CD300E,CMRF35-like molecule 2,Physical measures,X23100.Whole body fat mass,51817,0.0620320307302665,0.00638662637929543,0.0495142430268474,0.0745498184336855,2.888923463952e-22
CD300E,CMRF35-like molecule 2,Physical measures,X23101.Whole body fat-free mass,51825,-0.0282083093593203,0.00535591902639174,-0.0387059106510481,-0.0177107080675925,1.39905290546668e-07
CD300E,CMRF35-like molecule 2,Physical measures,X23102.Whole body water mass,51825,-0.0291682817828306,0.00537412473736538,-0.0397015662680668,-0.0186349972975945,5.76206512382805e-08
CD300E,CMRF35-like molecule 2,Physical measures,X23104.Body mass index (BMI),51825,-0.00945770909198369,0.0105701003145724,-0.0301751057085456,0.0112596875245783,0.370922954178808
CD300E,CMRF35-like molecule 2,Physical measures,X23105.Basal metabolic rate,51823,-0.0199098576955851,0.00584056946760312,-0.0313573738520872,-0.00846234153908301,0.000653218184522192
CD300E,CMRF35-like molecule 2,Physical measures,X23106.Impedance of whole body,51819,0.0570642893646993,0.00436009081501358,0.0485185113672727,0.0656100673621259,5.06059515977877e-39
CD300E,CMRF35-like molecule 2,Physical measures,X23107.Impedance of leg (right),51822,0.0159690498445747,0.00357853403633599,0.00895512313335611,0.0229829765557932,8.13485820137315e-06
CD300E,CMRF35-like molecule 2,Physical measures,X23108.Impedance of leg (left),51821,0.0125858615637973,0.00354425942781683,0.00563911308527636,0.0195326100423183,0.00038433359131184
CD300E,CMRF35-like molecule 2,Physical measures,X23109.Impedance of arm (right),51812,0.0703415429122284,0.00436446556857363,0.0617871903978241,0.0788958954266327,3.60026166898581e-58
CD300E,CMRF35-like molecule 2,Physical measures,X23110.Impedance of arm (left),51820,0.0715551024990134,0.00437471927545447,0.0629806527191226,0.0801295522789042,7.52221014201077e-60
CD300E,CMRF35-like molecule 2,Physical measures,X23111.Leg fat percentage (right),51821,0.0410080404253534,0.0105312734977245,0.0203667443698135,0.0616493364808934,9.88672461052315e-05
CD300E,CMRF35-like molecule 2,Physical measures,X23112.Leg fat mass (right),51820,0.0616495998670336,0.0121004727738411,0.0379326732303051,0.0853665265037622,3.51410589444243e-07
CD300E,CMRF35-like molecule 2,Physical measures,X23113.Leg fat-free mass (right),51820,-0.00102870781725632,0.00544013939218705,-0.0116913810259429,0.0096339653914303,0.850019091223151
CD300E,CMRF35-like molecule 2,Physical measures,X23114.Leg predicted mass (right),51819,-0.000626992162912271,0.00546086791534124,-0.0113302932769811,0.0100763089511566,0.908592222417023
CD300E,CMRF35-like molecule 2,Physical measures,X23115.Leg fat percentage (left),51816,0.0324791399553255,0.0108729842702432,0.0111680907856489,0.0537901891250021,0.00281849084235504
CD300E,CMRF35-like molecule 2,Physical measures,X23116.Leg fat mass (left),51816,0.0543653075651177,0.0121458641229501,0.0305594138841355,0.0781712012460999,7.63488578854912e-06
CD300E,CMRF35-like molecule 2,Physical measures,X23117.Leg fat-free mass (left),51814,0.00322657399351479,0.00558299238898914,-0.00771609108890392,0.0141692390759335,0.563316716199165
CD300E,CMRF35-like molecule 2,Physical measures,X23118.Leg predicted mass (left),51813,0.00372341841488116,0.00560400746196165,-0.00726043621056367,0.014707273040326,0.506426703723922
CD300E,CMRF35-like molecule 2,Physical measures,X23119.Arm fat percentage (right),51813,0.0754550031403137,0.00741834051789442,0.0609150557252406,0.0899949505553868,2.93832633521403e-24
CD300E,CMRF35-like molecule 2,Physical measures,X23120.Arm fat mass (right),51809,0.0473540575432064,0.00668049780143518,0.0342602818523934,0.0604478332340193,1.3895769154484e-12
CD300E,CMRF35-like molecule 2,Physical measures,X23121.Arm fat-free mass (right),51811,-0.0386694695542969,0.00520980983221147,-0.0488806968254314,-0.0284582422831624,1.18334722151411e-13
CD300E,CMRF35-like molecule 2,Physical measures,X23122.Arm predicted mass (right),51810,-0.0392229634296103,0.00520824766140185,-0.049431128845958,-0.0290147980132627,5.19331125553123e-14
CD300E,CMRF35-like molecule 2,Physical measures,X23123.Arm fat percentage (left),51807,0.0894547131019681,0.00831669052206314,0.0731539996787244,0.105755426525212,6.28322914723445e-27
CD300E,CMRF35-like molecule 2,Physical measures,X23124.Arm fat mass (left),51806,0.049627253025913,0.00684844587433882,0.0362042991122089,0.0630502069396171,4.39002338102873e-13
CD300E,CMRF35-like molecule 2,Physical measures,X23125.Arm fat-free mass (left),51806,-0.0326628489553396,0.00561360323002344,-0.0436655112861856,-0.0216601866244937,6.00331891482909e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23126.Arm predicted mass (left),51804,-0.032902010735527,0.00562005222618371,-0.0439173130988471,-0.0218867083722069,4.84210083239079e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23127.Trunk fat percentage,51802,0.0556232038782863,0.00420447092851649,0.0473824408583939,0.0638639668981786,7.85535131710739e-40
CD300E,CMRF35-like molecule 2,Physical measures,X23128.Trunk fat mass,51798,0.0565387991702516,0.00484968487825854,0.0470334168088648,0.0660441815316383,2.47093768925986e-31
CD300E,CMRF35-like molecule 2,Physical measures,X23129.Trunk fat-free mass,51792,-0.0384825017400384,0.00500079780503679,-0.0482840654379105,-0.0286809380421663,1.45943628439789e-14
CD300E,CMRF35-like molecule 2,Physical measures,X23130.Trunk predicted mass,51789,-0.0388411438076538,0.00500910972052649,-0.0486589988598857,-0.0290232887554219,9.20578591736202e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23400.Total Cholesterol,40436,-0.0364957421971783,0.00376368110758437,-0.0438725571680437,-0.0291189272263129,3.58016753456611e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40436,-0.015451395657287,0.00365110818991958,-0.0226075677095294,-0.00829522360504459,2.32941070089024e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40436,-0.00422552953879996,0.00364923652004056,-0.0113780331180795,0.00292697404047954,0.246913361399592
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23403.VLDL Cholesterol,40436,0.0207158499473742,0.00357619015012654,0.0137065172531262,0.0277251826416222,7.05594432809134e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40436,-0.0260770457014791,0.00364820333160813,-0.033227524231431,-0.0189265671715272,9.1915225410465e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23405.LDL Cholesterol,40436,-0.0252170090131139,0.00364818879989311,-0.0323674590609044,-0.0180665589653234,4.95238414374039e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23406.HDL Cholesterol,40436,-0.0806152611345113,0.00415777200824308,-0.0887644942706678,-0.0724660279983549,8.51420256197059e-83
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23407.Total Triglycerides,40436,0.036267208222622,0.00386219113227806,0.028697313603357,0.043837102841887,6.77090224026192e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23408.Triglycerides in VLDL,40436,0.0329628864279773,0.00386583578005765,0.0253858482990643,0.0405399245568903,1.6386508976088e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23409.Triglycerides in LDL,40436,0.0425305307976194,0.00384288923385772,0.0349984678992583,0.0500625936959805,2.29087716160234e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23410.Triglycerides in HDL,40436,0.030967972467194,0.00364152658078447,0.0238305803688565,0.0381053645655316,1.98975790606765e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40436,-0.0384070870481574,0.00383458466847626,-0.0459228729983709,-0.0308913010979439,1.52163766411998e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23412.Phospholipids in VLDL,40436,0.0301100217732491,0.003678702202372,0.0228997654566,0.0373202780898982,2.92758614364136e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23413.Phospholipids in LDL,40436,-0.0219661230510746,0.00362259979656846,-0.0290664186523488,-0.0148658274498004,1.36072815792002e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23414.Phospholipids in HDL,40436,-0.0671532525516273,0.0040459187051822,-0.0750832532137844,-0.0592232518894702,2.35849008604247e-61
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23415.Total Esterified Cholesterol,40436,-0.0413544437811858,0.00377226206128157,-0.0487480774212977,-0.0339608101410739,7.25199564811646e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40436,0.0178063575408347,0.00355578674183593,0.0108370155268362,0.0247756995548331,5.56675672934353e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40436,-0.0219518404937901,0.00364254072412922,-0.0290912203130834,-0.0148124606744968,1.71207578830464e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40436,-0.0829532015365486,0.00412605003364353,-0.09104025960249,-0.0748661434706073,8.38069119236923e-89
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23419.Total Free Cholesterol,40436,-0.0238247946824957,0.00373901104585544,-0.0311532563323724,-0.016496333032619,1.91745704921286e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40436,0.0245429308354861,0.0036384331426642,0.0174116018758643,0.0316742597951079,1.57768125233042e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23421.Free Cholesterol in LDL,40436,-0.0331261572147484,0.00367347083597913,-0.0403261600532674,-0.0259261543762293,2.13526261486052e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23422.Free Cholesterol in HDL,40436,-0.0667480804315093,0.00419232104499156,-0.0749650296796928,-0.0585311311833259,1.2245449542887e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40436,-0.0217385715599395,0.00375804314042771,-0.0291043361151778,-0.0143728070047012,7.40677821291321e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23424.Total Lipids in VLDL,40436,0.0297285440854966,0.0037537205896499,0.0223712517297828,0.0370858364412104,2.53535932657658e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23425.Total Lipids in LDL,40436,-0.02123750015884,0.003642780179748,-0.028377349311146,-0.0140976510065339,5.64872937242493e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23426.Total Lipids in HDL,40436,-0.0707967770200006,0.00409161125308604,-0.0788163350760492,-0.062777218963952,1.80264116595448e-66
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40436,-0.0739259330993437,0.00381858212344975,-0.0814103540613052,-0.0664415121373822,1.4912294721697e-82
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23428.Concentration of VLDL Particles,40436,0.027591159368513,0.00362502154654346,0.0204861171372879,0.0346962015997382,2.86434328122711e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23429.Concentration of LDL Particles,40436,-0.00191332185789554,0.00361903760919942,-0.00900663557192641,0.00517999185613533,0.597033058248966
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23430.Concentration of HDL Particles,40436,-0.0776586101406867,0.00382207054958829,-0.0851498684178797,-0.0701673518634936,1.22918117467077e-90
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40436,0.0242111159285837,0.00408313663646768,0.0162081681211071,0.0322140637360604,3.10045786468361e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40436,-0.0141821712684759,0.0037356559345223,-0.0215040569001396,-0.00686028563681218,0.000147334758396427
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40436,-0.0300731484110708,0.0044150028590554,-0.0387265540148193,-0.0214197428073222,9.99746591192703e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23434.Phosphoglycerides,40422,-0.0427232071441558,0.00384895881682829,-0.0502671664251393,-0.0351792478631724,1.59619904209771e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40422,0.0640547253553653,0.00406513025997833,0.0560870700458078,0.0720223806649228,1.60739506157529e-55
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23436.Total Cholines,40422,-0.0448489514698644,0.00385616367568996,-0.0524070322742167,-0.0372908706655121,3.85242969552009e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23437.Phosphatidylcholines,40422,-0.047566241340729,0.00385646852832316,-0.0551249196562424,-0.0400075630252156,8.54226416816701e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23438.Sphingomyelins,40421,-0.0353374946345944,0.00388542994314141,-0.0429529373231516,-0.0277220519460373,1.0563521670847e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23439.Apolipoprotein B,40436,-0.000106735042742762,0.00361783638171834,-0.00719769435091071,0.00698422426542518,0.976464232032028
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23440.Apolipoprotein A1,40436,-0.0717350229272941,0.00396184811513652,-0.0795002452329617,-0.0639698006216265,1.50345792027772e-72
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40436,0.0345939210422606,0.00363873442461745,0.0274620015700104,0.0417258405145108,2.23227809445381e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23442.Total Fatty Acids,40422,0.00233406794399313,0.00387598249189214,-0.00526285774011547,0.00993099362810173,0.547057929866651
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23443.Degree of Unsaturation,40422,-0.0728171556655371,0.00401924532990149,-0.080694876512144,-0.0649394348189302,1.245242290283e-72
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40422,-0.048234221098137,0.00377646461284695,-0.055636091739317,-0.040832350456957,3.55830058060831e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40422,-0.0123206150297701,0.00374231767957764,-0.0196555576817423,-0.00498567237779792,0.000996078742586167
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40422,-0.0233824091455144,0.00377237838015487,-0.030776270770618,-0.0159885475204109,5.8470241906207e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40422,0.0366481348758437,0.00396834258265774,0.0288701834138346,0.0444260863378529,2.89752082159068e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23448.Saturated Fatty Acids,40422,-0.000890597121313066,0.00395845929513908,-0.00864917733978567,0.00686798309715953,0.821993201602274
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23449.Linoleic Acid,40422,-0.00470406859628033,0.00370762364295308,-0.0119710109364684,0.00256287374390771,0.204546705297905
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23450.Docosahexaenoic Acid,40422,-0.0739575371888846,0.00394687364316687,-0.0816934095294917,-0.0662216648482776,1.63511147457304e-77
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40422,-0.0594903429136109,0.00376197278678869,-0.0668638095757167,-0.0521168762515051,6.65738561929498e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40422,-0.031066162955163,0.00422853301472169,-0.0393540876640175,-0.0227782382463085,2.1282400123572e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40422,-0.0644375014854425,0.00422392595100161,-0.0727163963494056,-0.0561586066214793,3.53747285202604e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40422,0.0951367719703421,0.0041212922386149,0.0870590391826569,0.103214504758027,5.24810728038823e-116
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40422,-0.0115228842023993,0.00395234938458725,-0.0192694889961903,-0.00377627940860832,0.00355667606524256
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40422,-0.0146501572739048,0.00406684903195942,-0.0226211813765452,-0.0066791331712643,0.000316327635807142
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40422,-0.080247728916909,0.00399352363401229,-0.0880750352395731,-0.0724204225942449,1.02797422809675e-88
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40422,-0.0861026345926743,0.00418002505678914,-0.0942954837039811,-0.0779097854813676,4.56527817271498e-93
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40420,0.0481481606584245,0.00375553597622105,0.0407873101450313,0.0555090111718178,1.92387778978752e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23460.Alanine,40429,-0.0119338447779538,0.00361598813192539,-0.0190211815165275,-0.00484650803938,0.000967931084356876
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23461.Glutamine,40391,-0.0100999421987629,0.00365409757576976,-0.0172619734472716,-0.00293791095025414,0.00571623078147932
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23462.Glycine,40415,0.0187324675427066,0.00348853983010575,0.0118949294756993,0.0255700056097139,7.99642295150214e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23463.Histidine,40416,-0.0293169770538132,0.00355836182865776,-0.0362913662379824,-0.022342587869644,1.87165951083187e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40425,-0.0120261060554323,0.00364119838994964,-0.0191628548997336,-0.00488935721113099,0.000959390304100438
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23465.Isoleucine,40432,-0.00334776527339381,0.00357116637273457,-0.0103472513639536,0.00365172081716595,0.348544847295379
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23466.Leucine,40433,-0.010811611736456,0.0036400116691724,-0.0179460346080339,-0.00367718886487812,0.00298035177432878
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23467.Valine,40425,-0.0154076615481416,0.00367263774184438,-0.0226060315221565,-0.00820929157412658,2.74033211894148e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23468.Phenylalanine,40433,0.036918763570687,0.00354812575729189,0.0299644370863949,0.0438730900549792,2.82889974854434e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23469.Tyrosine,40417,-0.00155202402787744,0.00358142180661347,-0.00857161076883984,0.00546756271308495,0.664763354205048
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23470.Glucose,40403,-0.0234390050620818,0.00377571871315743,-0.0308394137398703,-0.0160385963842932,5.50512887322581e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23471.Lactate,40403,0.0279143587948797,0.0035397138586499,0.0209765196319259,0.0348521979578335,3.31982695839094e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23472.Pyruvate,40393,0.02138063342739,0.00366097434164996,0.0142051237177561,0.0285561431370239,5.31693177478981e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23473.Citrate,40434,0.0343553765306342,0.00363286743171088,0.0272349563644809,0.0414757966967876,3.6058732292799e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23474.3-Hydroxybutyrate,40234,0.0297627216353418,0.00341501509074066,0.0230692920574901,0.0364561512131935,3.1853789296533e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23475.Acetate,40422,-0.0295046751845445,0.00368581926857851,-0.0367288809509584,-0.0222804694181306,1.27716312059076e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23476.Acetoacetate,40435,0.000561787540236532,0.00354225553306633,-0.00638103330457348,0.00750460838504655,0.873989188234557
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23477.Acetone,40435,-0.0109380952198066,0.00355862648631278,-0.0179130031329797,-0.0039631873066336,0.00211788989088911
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23478.Creatinine,39952,0.144817138064092,0.00403746119443336,0.136903714123003,0.152730562005182,9.67601627538379e-271
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23479.Albumin,40435,-0.0849068809226912,0.00362346714661247,-0.0920088765300517,-0.0778048853153308,2.03874962303245e-119
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23480.Glycoprotein Acetyls,40436,0.108514794518824,0.00382503094674886,0.101017733863196,0.116011855174452,8.88651016962922e-173
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40436,0.042565583315582,0.00389720049993896,0.0349270703357016,0.0502040962954624,1.13216629142589e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40436,0.0383731212432529,0.00389936050222345,0.030730374658895,0.0460158678276109,8.7123008528734e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40436,0.0423839871718273,0.00383801572735216,0.034861476346217,0.0499064979974375,2.9915545672458e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40436,0.0439019740110007,0.00382972013570539,0.0363957225450181,0.0514082254769832,2.64317918788812e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40436,0.0441312826290128,0.00380617685502467,0.0366711759931645,0.0515913892648612,5.83475730372288e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40436,0.0413651827880391,0.00385066777810565,0.033817873942952,0.0489124916331261,7.95069159075339e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40436,0.0326493037450093,0.00393222636718375,0.0249421400653292,0.0403564674246895,1.09552648256411e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40436,0.0373683017172757,0.00382714330241505,0.0298671008445422,0.0448695025900092,1.8564471273723e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40436,0.0353011510611036,0.00383718732236346,0.0277802639092712,0.0428220382129359,4.02228019687802e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40436,0.0378519639205186,0.00380360282903974,0.0303969023756007,0.0453070254654365,2.89988588075802e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40436,0.0344499177211636,0.00369741594837978,0.0272029824623393,0.041696852979988,1.34578220979026e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40436,0.0315329756237757,0.00362353038125897,0.0244308560765081,0.0386350951710433,3.56544275105394e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40436,0.0369641577897693,0.00377571651133901,0.0295637534275449,0.0443645621519938,1.4388616404932e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40436,0.0336489209056893,0.00388179997724996,0.0260405929502794,0.0412572488610993,4.79760346967442e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40436,0.0340727668315001,0.00379356315379975,0.0266373830500525,0.0415081506129476,2.95735567336027e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40436,0.0293336303413727,0.0037893111856485,0.0219065804175016,0.0367606802652438,1.04391772985888e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40436,0.0367844102988808,0.00376556564751978,0.029403901629742,0.0441649189680195,1.77440064858121e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40436,0.032132654393227,0.00366045152947554,0.0249581693954549,0.039307139390999,1.82448245313306e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40436,0.0305446763018108,0.00357375852663858,0.0235401095895992,0.0375492430140224,1.37681525229973e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40436,0.0332797656873362,0.00375389771601084,0.025922126163955,0.0406374052107175,8.41486994942289e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40436,0.02264817437368,0.00385093479521631,0.015100342175056,0.0301960065723039,4.15391268923846e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40436,0.0122594359404256,0.00360721148364245,0.00518930143248643,0.0193295704483648,0.000678992872061263
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40436,0.0146820756662763,0.00364537287362802,0.00753714483396536,0.0218270064985872,5.66113103645594e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40436,0.0119591808090702,0.00359808409018365,0.00490693599231022,0.0190114256258301,0.000890110277619665
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40436,-0.000170516990002706,0.00362475738587853,-0.00727504146632463,0.00693400748631921,0.962480087578302
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40436,-0.00653851552042794,0.00368541274128334,-0.0137619244933433,0.000684893452487407,0.0760555568240633
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40436,0.0081723840633948,0.00358890894864316,0.00113812252405421,0.0152066456027354,0.0227920847562971
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40436,0.0235063304505896,0.00377836818865027,0.016100728800835,0.0309119321003441,5.05353133405757e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40436,0.0347361174587057,0.00362406611819706,0.0276329478670394,0.0418392870503719,1.05910201407124e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40436,0.030644760256831,0.00360679455604448,0.0235754429269838,0.0377140775866781,2.12596582123634e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40436,0.0190121428977599,0.00356859820976518,0.0120176904066202,0.0260065953888997,1.00855323885261e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40436,0.0212804366695219,0.003527734391063,0.0143660772630384,0.0281947960760053,1.65180903938121e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40436,0.0275892468239658,0.00350471098102547,0.0207200133011558,0.0344584803467757,3.71139323044705e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40436,0.00954919651892524,0.00357672271573014,0.00253881999609416,0.0165595730417563,0.00759692341228062
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40436,0.0409965083443824,0.00373266125078062,0.0336804922928524,0.0483125243959124,5.79578246028412e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40436,0.0253938238114114,0.00365304682835686,0.0182338520278319,0.0325537955949908,3.7564101699374e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40436,0.025853117452491,0.00365137196037221,0.0186964284101615,0.0330098064948205,1.49738287015962e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40436,0.035185611600136,0.00364003284184074,0.0280511472301282,0.0423200759701439,4.8179546380188e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40436,0.0071174457797578,0.00372173510660005,-0.000177155029178289,0.0144120465886939,0.0558427775186287
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40436,-0.000578642537941069,0.00374923037088165,-0.0079271340648691,0.00676984898898696,0.877346484539377
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40436,0.0243516274414273,0.00366148965109835,0.0171751077252745,0.0315281471575801,3.010731755528e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40436,0.0512377043570382,0.00369904170657548,0.0439875826121502,0.0584878261019261,2.21522674516975e-43
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23523.Concentration of IDL Particles,40436,-0.00916458632372582,0.00366650518688226,-0.016350936490015,-0.00197823615743659,0.0124453167336397
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23524.Total Lipids in IDL,40436,-0.02403090607181,0.00376191398722223,-0.0314042574867656,-0.0166575546568545,1.72774293528716e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23525.Phospholipids in IDL,40436,-0.0151134804329069,0.00377780846606812,-0.0225179850264004,-0.00770897583941335,6.34680752761437e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23526.Cholesterol in IDL,40436,-0.0331752375908263,0.0037604012611574,-0.0405456240626948,-0.0258048511189578,1.23580690929324e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40436,-0.0356005778447056,0.00374960662646856,-0.042949806832584,-0.0282513488568272,2.51883399611091e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23528.Free Cholesterol in IDL,40436,-0.0254937158659108,0.00378666721820909,-0.0329155836136006,-0.018071848118221,1.72456303193684e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23529.Triglycerides in IDL,40436,0.0473045993218241,0.003755692257483,0.0399434424971574,0.0546657561464908,3.32394376433663e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40436,-0.00207448806999929,0.00363579425748986,-0.00920064481467941,0.00505166867468083,0.568296766545426
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23531.Total Lipids in Large LDL,40436,-0.0259644247571293,0.0036690268189663,-0.0331557173223032,-0.0187731321919553,1.53812741572627e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23532.Phospholipids in Large LDL,40436,-0.0271761266715015,0.00365071896825266,-0.0343315358492767,-0.0200207174937263,1.02614933725703e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23533.Cholesterol in Large LDL,40436,-0.029929721226134,0.00367766551655821,-0.0371379456385881,-0.0227214968136799,4.30352454581683e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40436,-0.027582498197015,0.00366397441782973,-0.0347638880559613,-0.0204011083380687,5.42552005367906e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40436,-0.0355464440589531,0.00371170755721686,-0.0428213908710981,-0.028271497246808,1.14392810987368e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23536.Triglycerides in Large LDL,40436,0.0411680527345101,0.00381271388875246,0.0336951335125552,0.0486409719564649,4.38282066891806e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40436,-0.00507819199631027,0.00361172076861031,-0.0121571647027865,0.00200078071016594,0.159734306403916
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40436,-0.0145828823617808,0.00362354567247625,-0.0216850318798342,-0.00748073284372732,5.73647169971634e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40436,-0.0162090475008515,0.00359669801978803,-0.023258575619636,-0.00915951938206692,6.63274126332362e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40436,-0.0175212552569445,0.00362245108387977,-0.0246212593813489,-0.0104212511325402,1.33141172880707e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40436,-0.0127608894147853,0.00363670621254885,-0.019888833591381,-0.00563294523818953,0.000451177380985657
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40436,-0.0291900489163549,0.00361829121320782,-0.0362818996942422,-0.0220981981384675,7.68974395309535e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40436,0.0424291081730225,0.00386826716095784,0.0348473045375451,0.0500109118084999,6.80973554186291e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40436,0.00525394323469618,0.00359973108173377,-0.00180152968550202,0.0123094161548944,0.144436823227624
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23545.Total Lipids in Small LDL,40436,-0.00893443089487995,0.0036302219903363,-0.0160496659959391,-0.00181919579382079,0.013860690496325
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23546.Phospholipids in Small LDL,40436,-0.00924992496038292,0.00361121102033648,-0.0163278985602424,-0.00217195136052342,0.0104328114394081
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23547.Cholesterol in Small LDL,40436,-0.0132112948665269,0.00361982100297497,-0.0203061440323578,-0.00611644570069597,0.000263373448631541
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40436,-0.00781815391296611,0.00364461887702097,-0.0149616069119272,-0.000674700914005009,0.0319580781598123
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40436,-0.0253591539923812,0.00359539376729692,-0.0324061257762832,-0.0183121822084793,1.81971057214764e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23550.Triglycerides in Small LDL,40436,0.0449049613623016,0.00389907987295813,0.0372627648113037,0.0525471579132996,1.43312933603428e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40436,-0.019954657246333,0.00419693828325248,-0.0281806562815079,-0.0117286582111582,2.00598197591251e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40436,-0.02164862852208,0.00422514515864539,-0.029929913033025,-0.0133673440111351,3.02989997024664e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40436,-0.0192198855536999,0.00422959755022726,-0.0275098967521453,-0.0109298743552544,5.5563863381646e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40436,-0.0283556072715074,0.00419323499244432,-0.0365743478566983,-0.0201368666863165,1.40594188585063e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40436,-0.0341465020766577,0.00425799115345261,-0.0424921647374248,-0.0258008394158906,1.13577609492316e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40436,-0.0079827142993561,0.00391308984745806,-0.0156523704003739,-0.000313058198338315,0.0413664492569977
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40436,0.0378757064408307,0.00377465251917153,0.0304773875032545,0.0452740253784069,1.26638895855538e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40436,-0.0536684433635032,0.00442300002849884,-0.0623375234193609,-0.0449993633076455,9.82218196812848e-34
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23559.Total Lipids in Large HDL,40436,-0.0549943594804816,0.00439855552773848,-0.0636155283148491,-0.0463731906461142,1.05836172419145e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23560.Phospholipids in Large HDL,40436,-0.0557067789807376,0.00434058450142222,-0.0642143246035252,-0.0471992333579501,1.62154364206379e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23561.Cholesterol in Large HDL,40436,-0.0568702538190141,0.00439608793138621,-0.0654865861645311,-0.0482539214734971,4.34672791893744e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40436,-0.0580316061457037,0.00438268762916343,-0.066621673898864,-0.0494415383925434,8.2320253217076e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40436,-0.0511757952241536,0.00439549557896775,-0.0597909665589304,-0.0425606238893768,3.33749936596634e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23564.Triglycerides in Large HDL,40436,0.0203831500078616,0.00373864664291073,0.0130554025877566,0.0277108974279666,5.05412765959288e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40436,-0.0735661246401074,0.00392609908022116,-0.0812612788373409,-0.065870970442874,1.64880533789576e-77
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40436,-0.0710735137645009,0.00389370019418591,-0.0787051661451053,-0.0634418613838965,1.08763938699025e-73
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40436,-0.0666950549549056,0.00387403797968722,-0.0742881693950926,-0.0591019405147187,7.9121274912583e-66
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40436,-0.0811182282669901,0.00392968133892831,-0.0888204036912896,-0.0734160528426906,1.88365799847774e-93
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40436,-0.0821558177297021,0.00390819106937699,-0.089815872225681,-0.0744957632337232,8.49388183379232e-97
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40436,-0.0737354386362454,0.00399048233945033,-0.081556784021568,-0.0659140932509227,1.90004907835008e-75
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40436,0.0236405447133486,0.0036122424929374,0.0165605494271913,0.0307205399995059,6.14852122391251e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40436,-0.0586205676097743,0.00354694874412932,-0.0655725871482677,-0.0516685480712808,7.49296475671627e-61
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23573.Total Lipids in Small HDL,40436,-0.0517703258941046,0.00359192285362248,-0.0588104946872046,-0.0447301571010045,8.42638465419359e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23574.Phospholipids in Small HDL,40436,-0.0517292794288305,0.00362953860275457,-0.0588431750902295,-0.0446153837674316,8.27732553922944e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23575.Cholesterol in Small HDL,40436,-0.0650303271521568,0.00354686154249774,-0.0719821757754524,-0.0580784785288612,2.52995295470849e-74
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40436,-0.0663615963877583,0.00350547098626207,-0.0732323195208319,-0.0594908732546846,4.64777955397304e-79
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40436,-0.0498779209329898,0.0036934441710979,-0.0571170715083417,-0.0426387703576379,2.4809668321336e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23578.Triglycerides in Small HDL,40436,0.0398183528798971,0.00372088947617523,0.0325254095065936,0.0471112962532005,1.23527964704587e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39554,0.0370034940916116,0.00338523713045252,0.0303684293159247,0.0436385588672986,1.04244976070892e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39554,0.0123536108513366,0.00356525852634285,0.00536570413970457,0.0193415175629686,0.000531709168551413
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39554,0.0142393373632331,0.0034769183379851,0.00742457742078232,0.0210540973056839,4.23654021888089e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39554,0.00540376037609619,0.0036325493268855,-0.00171603630459939,0.0125235570567918,0.136878744707381
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39554,-0.0213822310862029,0.00345158564201657,-0.0281473389445553,-0.0146171232278504,5.9833690991774e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40197,0.0363721756365708,0.00333825244937662,0.0298292008357927,0.042915150437349,1.51743795229836e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40197,-0.0190260560308647,0.00379814491796702,-0.02647042007008,-0.0115816919916493,5.52193141721845e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40197,-0.023598722507129,0.0038060832180829,-0.0310586456145715,-0.0161387993996865,5.77741857570034e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40197,0.00295858676188938,0.00360074844003681,-0.00409888018058276,0.0100160537043615,0.411283536306301
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40197,0.00547196281885358,0.00364483943103453,-0.0016719224659741,0.0126158481036813,0.133300493352512
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40431,0.0613718681849644,0.00353540902255147,0.0544424665007636,0.0683012698691653,6.90012221743363e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40431,0.0124002874168716,0.00351744621786157,0.00550609282986289,0.0192944820038802,0.000424080668384195
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40431,0.00268502211741434,0.00369526861097212,-0.00455770436009102,0.0099277485949197,0.467475048153534
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40431,0.033792057562889,0.00337435118606123,0.027178329238209,0.0404057858875691,1.54612961364614e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40431,-0.0354699077218084,0.00331154564515619,-0.0419605371863145,-0.0289792782573022,1.11354614776553e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40436,-0.0106571341370228,0.00371449589473832,-0.0179375460907099,-0.00337672218333571,0.00412225172944324
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40436,-0.0310113367734664,0.00387659844614223,-0.0386094697279052,-0.0234132038190277,1.33294565614646e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40436,-0.0344179126044711,0.00390442156810371,-0.0420705788779544,-0.0267652463309878,1.31685148317802e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40436,-0.0204833496089019,0.00379549069016476,-0.0279225113616249,-0.013044187856179,6.88222598994084e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40436,0.026870267880131,0.00385017854447364,0.0193239179329627,0.0344166178272993,3.09041759617579e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40436,-0.04776321696105,0.00376159549152145,-0.055135944124432,-0.0403904897976679,9.17734290112245e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40436,-0.0206402232079602,0.00369499559979608,-0.0278824145835605,-0.0133980318323599,2.36155523968781e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40436,0.00310045515307026,0.00359672106232097,-0.00394911812907885,0.0101500284352194,0.388687965827317
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40436,-0.0498248057733526,0.00377325198145521,-0.0572203796570048,-0.0424292318897004,1.32809010348716e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40436,0.0293563142047906,0.00372182185484574,0.022061543369293,0.0366510850402883,3.27808242569315e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40436,0.0880386364381981,0.00373406749728369,0.0807198641435221,0.0953574087328742,7.57639773465294e-121
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40436,-0.0620330319544864,0.00391378741757266,-0.0697040552929288,-0.054362008616044,3.77081757346867e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40436,-0.0682209906607074,0.00393243211731671,-0.0759285576106482,-0.0605134237107667,8.30988927622804e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40436,-0.00501279793635704,0.00385037163423773,-0.012559526339463,0.00253393046674891,0.19296941316591
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40436,0.048276374661831,0.00391849983431929,0.0405961149865652,0.0559566343370968,1.01464232214324e-34
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40436,0.0576386106465317,0.00351801373317605,0.0507433037295066,0.0645339175635567,7.6667068083624e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40436,-0.0741671851155702,0.0037025366415241,-0.0814241569329574,-0.0669102132981829,3.53133689593718e-88
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40436,-0.0790594462774206,0.00368341851428621,-0.0862789465654216,-0.0718399459894196,8.97803528454999e-101
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40436,-0.0162158131405443,0.00385440450829349,-0.0237704459767995,-0.00866118030428901,2.60094943530738e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40436,0.0725214590104391,0.00383086536738183,0.0650129628903707,0.0800299551305075,4.65080647292866e-79
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40436,-0.00554803511807391,0.00353416392485263,-0.0124749964107851,0.00137892617463725,0.116474554905741
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40436,-0.0723612858329436,0.00384048837469772,-0.0798886430473511,-0.0648339286185361,2.42501038643233e-78
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40436,-0.034080475336609,0.00357150021556692,-0.0410806157591202,-0.0270803349140979,1.59350252810723e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40436,-0.0560042615127437,0.003853354801783,-0.0635568369242384,-0.0484516861012491,1.48558641097421e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40436,0.0737348855332355,0.00381641473659811,0.0662547126495032,0.0812150584169678,3.12615619259187e-82
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40436,-0.012261397919371,0.00349557331919476,-0.0191127216249927,-0.00541007421374925,0.000453251539567058
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40436,-0.0487208533400388,0.00358051349174103,-0.0557386597838513,-0.0417030468962264,6.21154174750038e-42
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40436,0.00416099944504781,0.00364906344058158,-0.00299116489849208,0.0113131637885877,0.254181573125374
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40436,-0.0574157890866132,0.0039254243856995,-0.0651096208825842,-0.0497219572906422,3.88697915529061e-48
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40436,0.064522578336162,0.0036938825602765,0.0572825685180201,0.071762588154304,1.07867308415319e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40436,0.000848036943836946,0.00357222965181209,-0.00615353317371474,0.00784960706138864,0.812351785348765
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40436,-0.0413126651268747,0.00360289890444952,-0.0483743469795958,-0.0342509832741537,2.55350057740993e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40436,0.00186500976714493,0.00360417001197576,-0.00519916345632756,0.00892918299061742,0.604843029283689
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40436,-0.0569532270197369,0.00383815552682131,-0.0644760118523067,-0.0494304421871671,1.75753227636086e-49
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40436,0.0594870977815922,0.00378936424679739,0.0520599438578693,0.0669142517053151,3.99973543056806e-55
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40434,-0.00635204641274517,0.00411567110071087,-0.0144187617701385,0.00171466894464813,0.122758287566669
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40434,-0.0227893498133311,0.00410302681107475,-0.0308312823630376,-0.0147474172636246,2.83207329425254e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40434,-0.0619515657426266,0.00408775170083451,-0.0699635590762622,-0.0539395724089909,1.5914515177884e-51
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40434,0.0432882445184216,0.00435004544012192,0.0347621554557827,0.0518143335810606,2.91129716759795e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40434,0.0510055772954963,0.00408061741366501,0.0430075671647129,0.0590035874262797,1.10348080985448e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40436,0.00734302392961591,0.00426991385427559,-0.00102600722476425,0.0157120550839961,0.08550408559009
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40436,-0.0454281242297845,0.0042298895085716,-0.0537187076665849,-0.0371375407929842,8.17178193138864e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40436,-0.0504399376792544,0.00427016105531509,-0.058809453347672,-0.0420704220108368,4.59030873507345e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40436,-0.00897361002395776,0.00412140719727356,-0.0170515681306139,-0.00089565191730159,0.0294714996694915
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40436,0.0671624065985623,0.00408464077411497,0.0591565106812969,0.0751683025158276,2.95631626406884e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40436,0.0609843204288228,0.00399765479204991,0.053148917036405,0.0688197238212407,3.55272602413594e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40436,-0.0685486119334741,0.0038862308051609,-0.0761656243115895,-0.0609315995553588,5.58006924481169e-69
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40436,-0.063357875044512,0.00386815675625596,-0.0709394622867736,-0.0557762878022503,8.24608108198695e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40436,-0.0628996814706492,0.00418791218654812,-0.0711079893562835,-0.0546913735850149,1.21521120935199e-50
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40436,0.0670559345654723,0.00378169443630033,0.0596438134703237,0.074468055660621,1.1085963712007e-69
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40436,-7.84522447049513e-05,0.00373840100776859,-0.00740571821993138,0.00724881373052148,0.983257477918796
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40436,-0.0490476218169491,0.00372420276465033,-0.0563470592356638,-0.0417481843982344,2.09583025850494e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40436,-0.0508350106272551,0.0037353289169828,-0.0581562553045414,-0.0435137659499688,6.0440675301019e-42
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40436,0.00503440075310761,0.00381911151652455,-0.0024510578192805,0.0125198593254957,0.187451393155209
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40436,0.0742497553203465,0.00377043104639921,0.0668597104694041,0.081639800171289,2.55438238310961e-85
CD300E,CMRF35-like molecule 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51953,-0.00389537798546869,0.00307967145945995,-0.00993153404601019,0.00214077807507282,0.205929355888967
CD300E,CMRF35-like molecule 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51953,-0.00242055574808015,0.00301833520037718,-0.00833649274081943,0.00349538124465913,0.422588459456732
CD300E,CMRF35-like molecule 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50072,0.00349852193205844,0.00288199118518633,-0.00215018079090676,0.00914722465502365,0.22478745157084
CD300E,CMRF35-like molecule 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50072,0.000474152138943732,0.00313549111916221,-0.00567141045461419,0.00661971473250166,0.879802566619595
CD300E,CMRF35-like molecule 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50072,-0.00385288055426229,0.0030778913450294,-0.00988554759051992,0.00217978648199534,0.210657000636031
CD300E,CMRF35-like molecule 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50072,0.00228257848408454,0.00282251678451059,-0.00324955441355621,0.00781471138172529,0.418693370359102
CD300E,CMRF35-like molecule 2,Working and living environment,X24009.Traffic intensity on the nearest road,51953,-0.0580957235971366,0.0566119222722391,-0.169055091250725,0.052863644056452,0.304801611439773
CD300E,CMRF35-like molecule 2,Working and living environment,X24010.Inverse distance to the nearest road,51953,0.00313584127024588,0.00269331478798096,-0.00214305571419681,0.00841473825468856,0.244310321246243
CD300E,CMRF35-like molecule 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51953,0.00421355442798427,0.00269777825569048,-0.00107409095316907,0.00950119980913761,0.118332263163366
CD300E,CMRF35-like molecule 2,Working and living environment,X24012.Inverse distance to the nearest major road,51953,-0.00197879049032179,0.00274556945581957,-0.00736010662372815,0.00340252564308457,0.471087107714082
CD300E,CMRF35-like molecule 2,Working and living environment,X24013.Total traffic load on major roads,51953,-0.0399901552124577,0.0392997971922631,-0.117017757709293,0.0370374472843779,0.308892988981814
CD300E,CMRF35-like molecule 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51953,-0.0621531717693755,0.0381299006465214,-0.136887777036557,0.0125814334978064,0.10310500294863
CD300E,CMRF35-like molecule 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51953,-0.00555050789606591,0.00306209594851734,-0.0115522159551599,0.000451200163028073,0.0698967362333276
CD300E,CMRF35-like molecule 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51953,-0.00607919232818465,0.00305530036657504,-0.0120675810466717,-9.08036096975784e-05,0.0466316717503475
CD300E,CMRF35-like molecule 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51953,-0.00495378016700568,0.00302582279189325,-0.0108843928391164,0.000976832505105094,0.10160681851832
CD300E,CMRF35-like molecule 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51886,-0.00363483484701039,0.00298236654966072,-0.00948027328434539,0.00221060359032461,0.222939948202359
CD300E,CMRF35-like molecule 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51953,-0.00495912424904117,0.00271411213832798,-0.010278784040164,0.000360535542081664,0.0676861539290352
CD300E,CMRF35-like molecule 2,Working and living environment,X24021.Average evening sound level of noise pollution,51953,-0.00494496735162883,0.00271385103964255,-0.0102641153893282,0.000374180686070561,0.0684473504006759
CD300E,CMRF35-like molecule 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51953,-0.004962587437105,0.00271406928775939,-0.0102821632411134,0.000356988366903406,0.067490247278866
CD300E,CMRF35-like molecule 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51953,-0.0049766731495344,0.0027138794693172,-0.0102958769093961,0.000342530610327307,0.0666966230210624
CD300E,CMRF35-like molecule 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51953,-0.00499708230507973,0.00271387067364076,-0.0103162688254156,0.000322104215256157,0.0655866314810007
CD300E,CMRF35-like molecule 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48988,0.00498286453200667,0.00314861003831979,-0.00118841114310011,0.0111541402071135,0.113534658833521
CD300E,CMRF35-like molecule 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48988,0.00563268631249348,0.00287096928922454,5.58650561338723e-06,0.0112597861193736,0.0497800751294432
CD300E,CMRF35-like molecule 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48988,-0.00465178689927764,0.00281901448598886,-0.0101770552918158,0.000873481493260516,0.0989257749176822
CD300E,CMRF35-like molecule 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48988,0.00321638507669279,0.00296861000658029,-0.00260209053620458,0.00903486068959016,0.278612719380983
CD300E,CMRF35-like molecule 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48988,0.0048911006037259,0.00289448926140168,-0.000782098348621385,0.0105642995560732,0.0910794136703005
CD300E,CMRF35-like molecule 2,Working and living environment,"X24505.Water percentage, buffer 300m",48988,-0.000973219645231517,0.00283503596207906,-0.00652989013090648,0.00458345084044345,0.731388511151182
CD300E,CMRF35-like molecule 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52111,0.00378131237602429,0.00301187836804311,-0.00212196922534021,0.00968459397738879,0.209320069996436
CD300E,CMRF35-like molecule 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52111,0.00111162128687086,0.00284147179084053,-0.00445766342317659,0.00668090599691831,0.695642661706881
CD300E,CMRF35-like molecule 2,Working and living environment,X24508.Distance (Euclidean) to coast,52111,0.00388994636275244,0.00271532208623411,-0.00143208492626641,0.00921197765177128,0.151986016777683
CD300E,CMRF35-like molecule 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35668,0.0918865439539183,0.0412163109486869,0.011102574494492,0.172670513413345,0.0258088022546789
CD300E,CMRF35-like molecule 2,Health and medical history,X2704.Years since last cervical smear test,45604,0.100098656782635,0.0303277190495732,0.0406563274454712,0.159540986119798,0.000966494407773984
CD300E,CMRF35-like molecule 2,Health and medical history,X2714.Age when periods started (menarche),51448,-0.00273599773918035,0.0256801717974076,-0.0530691344620993,0.0475971389837386,0.915153716355894
CD300E,CMRF35-like molecule 2,Health and medical history,X2734.Number of live births,52281,0.0247938685583805,0.0247016809556385,-0.023621426114671,0.073209163231432,0.315516520084788
CD300E,CMRF35-like molecule 2,Health and medical history,X2744.Birth weight of first child,46502,-0.213001934158942,0.0275534864166893,-0.267006767535653,-0.158997100782231,1.11704621858478e-14
CD300E,CMRF35-like molecule 2,Health and medical history,X2754.Age at first live birth,43227,-0.0212740125036161,0.00343605819296021,-0.0280086865618181,-0.014539338445414,6.08700108650639e-10
CD300E,CMRF35-like molecule 2,Health and medical history,X2764.Age at last live birth,43177,-0.0150762870323539,0.0033178060651964,-0.0215791869201388,-0.00857338714456893,5.55275826094004e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X2794.Age started oral contraceptive pill,45804,0.00244654845771844,0.00366840931483207,-0.00474353379935243,0.0096366307147893,0.504828192410782
CD300E,CMRF35-like molecule 2,Health and medical history,X2804.Age when last used oral contraceptive pill,43814,-0.00349220032883024,0.00318278152675107,-0.00973045212126234,0.00274605146360186,0.27256041806634
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2867.Age started smoking in former smokers,30114,-0.00914365042873146,0.0063216163148578,-0.0215340184058527,0.00324671754838983,0.148117531110981
CD300E,CMRF35-like molecule 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35632,-0.0585548956322523,0.0475915781359215,-0.151834388778659,0.0347245975141539,0.218587260361065
CD300E,CMRF35-like molecule 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35623,-0.0388191265684324,0.0517306219773547,-0.140211145644048,0.0625728925071828,0.453024193479063
CD300E,CMRF35-like molecule 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35663,0.0910259346342506,0.0561174670769854,-0.0189643008366408,0.201016170105142,0.104818488628956
CD300E,CMRF35-like molecule 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35617,0.017043620632981,0.0539861087909301,-0.088769152597242,0.122856393863204,0.752233230819014
CD300E,CMRF35-like molecule 2,Mental health,X28739.Difficulty with standing for long periods,35675,0.307479129526053,0.047334024723041,0.214704441068892,0.400253817983213,8.60055954332249e-11
CD300E,CMRF35-like molecule 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35703,0.287081842776064,0.0508875017876111,0.187342339272346,0.386821346279782,1.72646646062314e-08
CD300E,CMRF35-like molecule 2,Mental health,X28741.Difficulty learning a new task,35592,0.0899390319092907,0.0568008451281785,-0.0213906245419391,0.201268688360521,0.113356416447375
CD300E,CMRF35-like molecule 2,Mental health,X28742.Difficulty with joining in community activities,35312,0.227134114111143,0.0599049759237875,0.10972036130052,0.344547866921767,0.000150506694053693
CD300E,CMRF35-like molecule 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35624,0.111515632858015,0.0503021235131967,0.0129234707721496,0.210107794943881,0.0266488257373124
CD300E,CMRF35-like molecule 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35697,0.168651365442927,0.0740232466727509,0.0235658019643352,0.313736928921519,0.0227240051901647
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30084,0.0576488956373178,0.0558935360231523,-0.0519024349680607,0.167200226242696,0.302395039890686
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2897.Age stopped smoking,30125,0.0375405437994752,0.00647692050352781,0.0248457796125606,0.0502353079863897,7.15516346879811e-09
CD300E,CMRF35-like molecule 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34548,-0.00406239268843141,0.0086226821796978,-0.0209628497606391,0.0128380643837763,0.637559040160801
CD300E,CMRF35-like molecule 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34548,0.00472395981126563,0.00919045785251114,-0.0132893375796562,0.0227372572021875,0.607258335477846
CD300E,CMRF35-like molecule 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34548,0.0197001218698194,0.0305640843931932,-0.0402054835408393,0.079605727280478,0.519232614400514
CD300E,CMRF35-like molecule 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34548,-0.00434210051446123,0.0324213555352321,-0.0678879573635161,0.0592037563345937,0.893462831782076
CD300E,CMRF35-like molecule 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34548,0.0163404585209756,0.0341643259606779,-0.0506216203619531,0.0833025374039043,0.632454105541028
CD300E,CMRF35-like molecule 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34548,-0.0385577719701258,0.0282333421783133,-0.0938951226396199,0.0167795786993682,0.17206916699987
CD300E,CMRF35-like molecule 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34548,-0.023716077982388,0.0129900083902562,-0.0491764944272902,0.00174433846251417,0.0679224388687932
CD300E,CMRF35-like molecule 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34548,0.0210618855351929,0.02307569144448,-0.0241664696959878,0.0662902407663736,0.361406135328983
CD300E,CMRF35-like molecule 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34478,0.017712906993141,0.0570347742269566,-0.094075250491694,0.129501064477976,0.756139097133004
CD300E,CMRF35-like molecule 2,Mental health,X29003.Recent feelings of depression,34464,-0.018226333491006,0.0544736971563299,-0.124994779917413,0.0885421129354006,0.73794168819708
CD300E,CMRF35-like molecule 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34481,0.0386603411574834,0.0446524241058792,-0.0488584100900399,0.126179092405007,0.386617218656484
CD300E,CMRF35-like molecule 2,Mental health,X29005.Recent feelings of tiredness or low energy,34489,0.152434813251834,0.0453864537210653,0.0634773639585459,0.241392262545122,0.000786307654860849
CD300E,CMRF35-like molecule 2,Mental health,X29006.Recent poor appetite or overeating,34496,0.0923088678640842,0.0586570389495814,-0.0226589284770954,0.207276664205264,0.115587198212825
CD300E,CMRF35-like molecule 2,Mental health,X29007.Recent feelings of inadequacy,34449,0.0101910004125452,0.058852780234494,-0.105160448847063,0.125542449672153,0.862528462727365
CD300E,CMRF35-like molecule 2,Mental health,X29008.Recent trouble concentrating on things,34496,-0.0382943302489209,0.0597634527912532,-0.155430697719777,0.0788420372219353,0.521689981962469
CD300E,CMRF35-like molecule 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34483,0.11191541390399,0.104626922875996,-0.093153354932963,0.316984182740942,0.284797347696316
CD300E,CMRF35-like molecule 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34418,0.285480223553952,0.116601211983976,0.0569418480653585,0.514018599042546,0.014368457766624
CD300E,CMRF35-like molecule 2,Mental health,X29038#0.Substances taken for depression_None of options listed,33158,0.00914999685848262,0.0177603571198495,-0.0256603030964225,0.0439602968133877,0.606431823069079
CD300E,CMRF35-like molecule 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33158,-0.0299140644295327,0.0356973328772554,-0.0998808368689532,0.0400527080098878,0.40205843658739
CD300E,CMRF35-like molecule 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33158,-0.00435937543220455,0.0167189435603699,-0.0371285048105296,0.0284097539461205,0.794295582075228
CD300E,CMRF35-like molecule 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33158,0.0387362018740704,0.0480066737466704,-0.0553568786694035,0.132829282417544,0.419750739852639
CD300E,CMRF35-like molecule 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33158,-0.0175601661900816,0.0305485728852333,-0.0774353690451389,0.0423150366649756,0.565422677877933
CD300E,CMRF35-like molecule 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33158,0.0536141414043399,0.0318185637255282,-0.00875024349769528,0.115978526306375,0.0920252515373917
CD300E,CMRF35-like molecule 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33158,0.000263636881940217,0.03642089364926,-0.0711213146706094,0.0716485884344898,0.994224635937995
CD300E,CMRF35-like molecule 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33158,0.0150494485083906,0.0428751885105729,-0.0689859209723322,0.0990848179891134,0.725592338783475
CD300E,CMRF35-like molecule 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33158,0.0136860215937519,0.0326504082624271,-0.0503087786006052,0.0776808217881091,0.67510335687943
CD300E,CMRF35-like molecule 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33158,0.00273409290983929,0.0179247129292828,-0.032398344431555,0.0378665302512336,0.878770861785265
CD300E,CMRF35-like molecule 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33158,-0.00630740848786082,0.0271312165833069,-0.0594845929911423,0.0468697760154206,0.816172308276018
CD300E,CMRF35-like molecule 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33158,-0.0125368315718899,0.0420137690801539,-0.0948838189689915,0.0698101558252117,0.765406411220884
CD300E,CMRF35-like molecule 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33158,-0.00489858736361697,0.056432214390595,-0.115505727569183,0.105708552841949,0.9308286645246
CD300E,CMRF35-like molecule 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33158,-0.0467342997157629,0.0361860666735171,-0.117658990395856,0.0241903909643305,0.196564693666838
CD300E,CMRF35-like molecule 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33158,0.0505412445857106,0.061837760714802,-0.0706607664153013,0.171743255586722,0.413767890609106
CD300E,CMRF35-like molecule 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33158,0.000196923623175306,0.0586803558591229,-0.114816573860706,0.115210421107056,0.997322485361309
CD300E,CMRF35-like molecule 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33158,0.00609416771213993,0.0310283217587278,-0.0547213429349665,0.0669096783592463,0.844296501696967
CD300E,CMRF35-like molecule 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33158,-0.00831122309909641,0.030571371505141,-0.0682311112491728,0.05160866505098,0.785733850320512
CD300E,CMRF35-like molecule 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33158,0.00487930413219246,0.0418478208332552,-0.0771424247009876,0.0869010329653726,0.907182601333236
CD300E,CMRF35-like molecule 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34332,-0.0811277960885133,0.0506345728320614,-0.180371558839354,0.018115966662327,0.109138634261404
CD300E,CMRF35-like molecule 2,Mental health,X29059.Recent inability to stop or control worrying,34345,0.00168702322632494,0.0518658679426908,-0.0999700779413491,0.103344124393999,0.974052715442719
CD300E,CMRF35-like molecule 2,Mental health,X29060.Recent worrying too much about different things,34335,-0.0490337688802365,0.0487044134869487,-0.144494419314656,0.0464268815541831,0.314073653239682
CD300E,CMRF35-like molecule 2,Mental health,X29061.Recent trouble relaxing,34342,-0.0580732575942393,0.0515152696619004,-0.159043186131564,0.0428966709430855,0.259642244780796
CD300E,CMRF35-like molecule 2,Mental health,X29062.Recent restlessness,34353,-0.0139474067192789,0.0751922426521785,-0.161324202317549,0.133429388878991,0.852848548087543
CD300E,CMRF35-like molecule 2,Mental health,X29063.Recent easy annoyance or irritability,34318,-0.068656149293934,0.0541962838402121,-0.17488086562075,0.0375685670328818,0.205254763006547
CD300E,CMRF35-like molecule 2,Mental health,X29064.Recent feelings of foreboding,34306,0.00834830886270272,0.0581961595665427,-0.105716163887721,0.122412781613126,0.885936783968485
CD300E,CMRF35-like molecule 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33158,-0.018551921661201,0.0175338919100139,-0.0529183498048283,0.0158145064824263,0.290057133343647
CD300E,CMRF35-like molecule 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33158,-0.0188354425414083,0.0308309649678043,-0.0792641338783047,0.0415932487954881,0.541264425192983
CD300E,CMRF35-like molecule 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33158,-0.00955360028048212,0.038249509457959,-0.0845226388180818,0.0654154382571175,0.802770703493702
CD300E,CMRF35-like molecule 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33158,0.0400079753846489,0.0420080370767642,-0.0423277772858089,0.122343728055107,0.340926381725674
CD300E,CMRF35-like molecule 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,33158,-0.00453646389171873,0.0287663945496419,-0.0609185972090169,0.0518456694255794,0.874696762657973
CD300E,CMRF35-like molecule 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33158,-0.011049354874745,0.0285723160660246,-0.0670510943641532,0.0449523846146632,0.698976359261358
CD300E,CMRF35-like molecule 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33158,0.0076021503183807,0.0291278777952824,-0.0494884901603727,0.0646927907971341,0.794104658184729
CD300E,CMRF35-like molecule 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33158,-0.0259278491805356,0.0261434149397936,-0.077168942462531,0.0253132441014598,0.321344865048903
CD300E,CMRF35-like molecule 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33158,-0.0214506234625609,0.0352972673041744,-0.0906332673787426,0.0477320204536208,0.543393403793986
CD300E,CMRF35-like molecule 2,Mental health,X29076.Felt loved as a child,34311,-0.0349646144969053,0.0479783991694577,-0.129002276869042,0.0590730478752317,0.466167375980449
CD300E,CMRF35-like molecule 2,Mental health,X29077.Physically abused by family as a child,34324,-0.0438196751022512,0.0669117400409285,-0.174966685582471,0.0873273353779687,0.512555326928983
CD300E,CMRF35-like molecule 2,Mental health,X29078.Felt hated by family member as a child,34305,0.0555249607386549,0.061832718728573,-0.0656671679693482,0.176717089446658,0.369214574227953
CD300E,CMRF35-like molecule 2,Mental health,X29079.Sexually molested as a child,34195,-0.106245359948126,0.0797202800710692,-0.262497108887422,0.0500063889911692,0.18265262459544
CD300E,CMRF35-like molecule 2,Mental health,X29080.Someone to take to doctor when needed as a child,34278,-0.0451867778166173,0.0664052026451843,-0.175340975001179,0.0849674193679439,0.49622266706517
CD300E,CMRF35-like molecule 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34304,-0.00928265453843819,0.0823473240487937,-0.170683409674074,0.152118100597197,0.910250372497608
CD300E,CMRF35-like molecule 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34223,-0.0452696159774585,0.0621274864027851,-0.167039489326917,0.0765002573720004,0.466229084032082
CD300E,CMRF35-like molecule 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34305,-0.0350737199007823,0.0695975597979119,-0.17148493710469,0.101337497303125,0.614307482764274
CD300E,CMRF35-like molecule 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34263,0.119148582603891,0.0847985145678595,-0.047056505949114,0.285353671156895,0.160029555938764
CD300E,CMRF35-like molecule 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34268,-0.0333038199966421,0.0858052963794124,-0.20148220090029,0.134874560907006,0.697926435946013
CD300E,CMRF35-like molecule 2,Mental health,X29086.Experienced a violent or sexual assault,34300,0.148041666828219,0.0802407219753285,-0.00923014824342491,0.305313481899863,0.0650720175517562
CD300E,CMRF35-like molecule 2,Mental health,X29087.Experienced a life-threatening injury or illness,34310,0.267129139956938,0.0570034401469711,0.155402397268875,0.378855882645001,2.82062056724084e-06
CD300E,CMRF35-like molecule 2,Mental health,X29088.Experienced a marital separation or divorce,34318,-0.0363630426175857,0.0508374381142095,-0.136004421321436,0.063278336086265,0.474452487310686
CD300E,CMRF35-like molecule 2,Mental health,X29089.Experienced the death of a spouse or partner,34326,-0.044645385729876,0.0639200403123921,-0.169928664742165,0.0806378932824126,0.484908026653634
CD300E,CMRF35-like molecule 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34310,0.0358812211804751,0.0644389169884279,-0.0904190561168435,0.162181498477794,0.577659417907423
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34325,-0.411117180730418,0.0429866079216966,-0.495370932256943,-0.326863429203892,1.40706680277185e-21
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33056,-0.313437612930462,0.0537956195763809,-0.418877027300169,-0.207998198560756,5.86555886954957e-09
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33074,-0.260097848386156,0.0549761843690159,-0.367851169749427,-0.152344527022885,2.2685834599428e-06
CD300E,CMRF35-like molecule 2,Mental health,X29104.Ever used cannabis,34319,-0.09897910915885,0.0664434868742507,-0.229208343432381,0.0312501251146813,0.136342047957053
CD300E,CMRF35-like molecule 2,Mental health,X29108.Ever thought that life not worth living,34264,-0.0056063375894614,0.0517234658512478,-0.106984330657907,0.0957716554789842,0.913688072444945
CD300E,CMRF35-like molecule 2,Mental health,X29109.Ever contemplated self-harm,34299,0.0506497273304996,0.0685516357864648,-0.0837114788109714,0.185010933471971,0.460012587141894
CD300E,CMRF35-like molecule 2,Mental health,X29111.Ever self-harmed,34314,0.130359313615921,0.105581986173233,-0.0765813792836145,0.337300006515457,0.216981344770487
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34307,-0.0542707290728695,0.0727301512899904,-0.196821825601251,0.0882803674555116,0.455568642590101
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33881,-0.0681111624166567,0.0375547663277104,-0.141718504418969,0.00549617958565567,0.0697635652298641
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33881,-0.098092760848584,0.0288682672019205,-0.154674564564348,-0.0415109571328198,0.00068175137757021
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33881,-0.0903655515839112,0.0291980441088161,-0.147593718037191,-0.0331373851306317,0.00197443955109671
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33881,-0.0688276641978052,0.0376240539060268,-0.142570809853618,0.0049154814580074,0.0673783526476816
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34301,-0.186759592744472,0.047869641705613,-0.280584090487473,-0.0929350950014704,9.62661854043954e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X29153.Pain or discomfort today,34314,0.175408966227655,0.0457100384614812,0.0858172908431517,0.265000641612158,0.000125106006751457
CD300E,CMRF35-like molecule 2,Mental health,X29154.Anxiety or depression today,34314,-0.0186594515146213,0.0548516184721831,-0.1261686237201,0.0888497206908576,0.733727842416948
CD300E,CMRF35-like molecule 2,Mental health,X29166.Frequency of confiding in someone close,34065,-0.023650556840457,0.0444596725864051,-0.110791515109811,0.063490401428897,0.594769278616187
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34278,0.028355669552062,0.00921910630831896,0.0102862211877569,0.0464251179163672,0.00210550409867664
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34278,-0.020819963660871,0.00904426692570044,-0.0385467268352438,-0.00309320048649811,0.0213555994297758
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34278,-0.0176258434259497,0.0132201287298175,-0.0435372957363919,0.00828560888449256,0.182478034224146
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34278,0.00118742346769475,0.0115513365464464,-0.0214531961633401,0.0238280430987296,0.918127508380218
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34278,-0.0580456400740572,0.0171886147614685,-0.0917353250065355,-0.024355955141579,0.000735701759308683
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34278,-0.00184430892537094,0.00905189066315045,-0.0195860146251458,0.0158973967744039,0.838554277821554
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34280,0.0135415095593271,0.0100685957358026,-0.00619293808284605,0.0332759572015002,0.178680380133128
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34280,-0.0195890029634459,0.0140857866973023,-0.0471971448901583,0.00801913896326661,0.164350071163641
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34280,0.0448637121159006,0.0293386240877676,-0.012639991096124,0.102367415327925,0.126254756316838
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34280,0.0146029072255681,0.0194135973456309,-0.0234477435718684,0.0526535580230046,0.451948829421829
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34280,-0.0562233315318551,0.0276038713559391,-0.110326919389496,-0.00211974367421434,0.0416976810627579
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34280,-0.0141387401762213,0.0143495869750972,-0.0422639306474118,0.0139864502949692,0.324497835550382
CD300E,CMRF35-like molecule 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34168,-0.0163855184080795,0.0554791037225059,-0.125124561704191,0.0923535248880322,0.767736070021265
CD300E,CMRF35-like molecule 2,Mental health,X29172.Freuency of feeling that lacks companionship,34253,0.0534282647068924,0.0494444797169835,-0.0434829155383953,0.15033944495218,0.279914634859052
CD300E,CMRF35-like molecule 2,Mental health,X29173.Frequency of feeling left out,34193,0.00383553336310437,0.0515378649891789,-0.0971786820156862,0.104849748741895,0.940676404291194
CD300E,CMRF35-like molecule 2,Mental health,X29174.Frequency of feeling isolated from others,34226,0.0084747813443705,0.0536531201368687,-0.0966853341238922,0.113634896812633,0.874495481192369
CD300E,CMRF35-like molecule 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34299,-0.023075751954779,0.0450124638152028,-0.111300181032577,0.0651486771230185,0.608205926830111
CD300E,CMRF35-like molecule 2,Mental health,X29176.Ability to make it through stressful events,34299,0.0147164212950709,0.0433855335899282,-0.0703192245411885,0.0997520671313302,0.734465466201025
CD300E,CMRF35-like molecule 2,Mental health,X29177.Quick recovery from stressful events,34299,-0.0206049090201854,0.0443246743628149,-0.107481270771303,0.0662714527309319,0.642039722354314
CD300E,CMRF35-like molecule 2,Mental health,X29178.Hard to snap back when something bad happens,34299,-0.00314132364340052,0.0435627174208056,-0.0885242497881795,0.0822416025013785,0.942515539111129
CD300E,CMRF35-like molecule 2,Mental health,X29179.Comes through difficult times with little trouble,34299,0.028195418609434,0.0442300581174394,-0.0584954953007472,0.114886332519615,0.523832342125732
CD300E,CMRF35-like molecule 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34299,0.00643233597400329,0.0442508595147558,-0.0802993486749181,0.0931640206229247,0.884429066908247
CD300E,CMRF35-like molecule 2,Mental health,X29181.General happiness,34240,0.0225333400423042,0.0460231198340672,-0.0676719748324676,0.112738654917076,0.624421485529761
CD300E,CMRF35-like molecule 2,Mental health,X29182.Belief that own life is meaningful,34145,0.0287838734355328,0.0452727502213614,-0.0599507169983355,0.117518463869401,0.52492959429072
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29657,0.027252062337132,0.0568306927136799,-0.0841360953816805,0.138640220055945,0.631581278650683
CD300E,CMRF35-like molecule 2,Health and medical history,X2946.Father's age,30763,-0.00364636955608375,0.00815861634631631,-0.0196372575948637,0.0123445184826962,0.65493747407314
CD300E,CMRF35-like molecule 2,Health and medical history,X2966.Age high blood pressure diagnosed,30388,-0.0291656639504471,0.00734793578331846,-0.0435676180857512,-0.0147637098151429,7.29555515924106e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51374,0.0424113549022165,0.00284424147973492,0.036836641601936,0.0479860682024969,4.41078129193084e-50
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51374,0.0125983549587678,0.00334341033729668,0.00604527069766627,0.0191514392198693,0.000164835464371895
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30020.Haemoglobin concentration,51374,-0.0403238757806009,0.00362939273153592,-0.0474374855344113,-0.0332102660267905,1.28919146718306e-28
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30030.Haematocrit percentage,51374,-0.0236774071194359,0.00352552722180089,-0.0305874404741656,-0.0167673737647061,1.90509313441673e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30040.Mean corpuscular volume,51374,-0.0436088736558898,0.00279251710813246,-0.0490822071878294,-0.0381355401239502,9.80171023669749e-55
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51373,-0.0535667377579614,0.00279173682137503,-0.0590385419278565,-0.0480949335880664,1.64663707116515e-81
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51373,-0.0335628908944249,0.00274489779787431,-0.0389428905782586,-0.0281828912105913,2.73760854844659e-34
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51374,0.0474830732557819,0.00264117748189563,0.0423063653912665,0.0526597811202974,7.63162722823268e-72
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30080.Platelet count,51374,0.00849893426953913,0.0028148778512419,0.00298177368110501,0.0140160948579732,0.00253604644635296
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30090.Platelet crit,51374,0.0231884199643789,0.00288104277020514,0.0175415761347768,0.028835263793981,8.71583232745197e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51374,0.0200925890324808,0.00272360446564147,0.0147543242798235,0.0254308537851381,1.66314809214899e-13
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30110.Platelet distribution width,51374,0.0105276169755542,0.00272258317776008,0.00519135394714444,0.0158638800039639,0.000110543150073368
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30120.Lymphocyte count,51335,-0.0180764247787865,0.00283571662066536,-0.0236344293552906,-0.0125184202022824,1.8647369499489e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30130.Monocyte count,51335,0.110338000984822,0.00280008751660343,0.104849829452279,0.115826172517365,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30140.Neutrophill count,51335,0.0402169362848395,0.00282292561890246,0.0346840020717907,0.0457498704978883,6.92159109055143e-46
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30150.Eosinophill count,51335,0.0467834584054262,0.00277477917049199,0.0413448912312619,0.0522220255795905,1.8704093024746e-63
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30160.Basophill count,51335,0.164467890279176,0.0279244430683877,0.109735981865136,0.219199798693216,3.91386910440947e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30170.Nucleated red blood cell count,51335,0.340957232951821,0.116554626882546,0.11251016426203,0.569404301641611,0.00344412073417584
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30180.Lymphocyte percentage,51335,-0.0570266698103638,0.00278025332447037,-0.0624759663263257,-0.0515773732944018,8.76647556840888e-93
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30190.Monocyte percentage,51335,0.0896518853354095,0.00278701664508363,0.0841893327110456,0.0951144379597734,8.38516758012495e-223
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30200.Neutrophill percentage,51335,0.0190497102145982,0.00277538440398341,0.0136099567827908,0.0244894636464057,6.85040157072451e-12
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30210.Eosinophill percentage,51335,0.0328307810535715,0.00275071113765821,0.0274393872237614,0.0382221748833816,9.3666286181496e-33
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30220.Basophill percentage,51335,0.00733022060704017,0.00263815488056925,0.00215943704112444,0.0125010041729559,0.00546415562945317
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51335,0.342976498884292,0.116558820635365,0.114521210438975,0.571431787329608,0.00325832181706771
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30240.Reticulocyte percentage,50886,0.01266057955874,0.00289700124863367,0.00698245711141797,0.018338702006062,1.24585101923068e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30250.Reticulocyte count,50886,0.0147989057665773,0.00299466304220774,0.00892936620385008,0.0206684453293044,7.78935623137934e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30260.Mean reticulocyte volume,50886,0.00269442010602899,0.00277754282199622,-0.00274956382508361,0.00813840403714159,0.332018836982919
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30270.Mean sphered cell volume,50886,-0.0294157564723893,0.00280254382467196,-0.0349087423687464,-0.0239227705760323,1.01158972135856e-25
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50886,0.0214499936072089,0.00292511118866723,0.0157167756774212,0.0271832115369967,2.31430719571195e-13
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50886,0.0192274717754436,0.00297585442629247,0.0133947970999104,0.0250601464509768,1.05710811424994e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50886,0.021259834046954,0.00305317207065817,0.015275616788464,0.027244051305444,3.40418093082509e-12
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30500.Microalbumin in urine,32215,0.0557227228184981,0.00575008648124393,0.04445255331526,0.0669928923217362,4.400937444475e-22
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51433,0.0282446333902925,0.00289900356281185,0.0225625864071813,0.0339266803734037,2.15436220832338e-22
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30520.Potassium in urine,51380,-0.000491118882469831,0.00270216214980468,-0.005787356696087,0.00480511893114734,0.855780028275897
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30530.Sodium in urine,51350,-0.0154368537885501,0.00284667935102791,-0.0210163453165648,-0.0098573622605354,5.91914774275937e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30600.Albumin,48591,-0.0862097407834174,0.00293494409702472,-0.0919622312135858,-0.0804572503532489,2.26917178211449e-186
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30610.Alkaline phosphatase,50975,0.0852449028123522,0.00279168793022976,0.0797731944691019,0.0907166111556025,2.71183296829258e-201
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30620.Alanine aminotransferase,50984,0.0129296943294311,0.0029602641538567,0.00712757658787194,0.0187318120709902,1.26008421245262e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30630.Apolipoprotein A,48377,-0.0659698995852099,0.00324282259159814,-0.0723258318647423,-0.0596139673056776,3.1458375863585e-91
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30640.Apolipoprotein B,50872,0.00174083438522577,0.00282065478757709,-0.00378764899842532,0.00726931776887687,0.537125378262401
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30650.Aspartate aminotransferase,50904,0.0332140052932353,0.0028578162131541,0.0276126855154532,0.0388153250710173,3.78564790270615e-31
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30660.Direct bilirubin,45103,-0.00519507269667972,0.00321479664817027,-0.0114960741270934,0.00110592873373401,0.10611219036486
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30670.Urea,50970,0.0635477522909947,0.00293096344883519,0.0578030639312778,0.0692924406507117,2.42414912774931e-103
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30680.Calcium,48598,-0.0180313112417761,0.00286299304794605,-0.0236427776157504,-0.0124198448678019,3.06580822007564e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30690.Cholesterol,50983,-0.0144175970382845,0.00290581562096806,-0.0201129956553819,-0.00872219842118711,7.03343837042766e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30700.Creatinine,50976,0.142774738056195,0.00310499789356917,0.1366889421848,0.148860533927591,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30710.C-reactive protein,50917,0.146454424178732,0.00296967756219037,0.140633856156839,0.152274992200625,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30720.Cystatin C,50980,0.271092885646813,0.00269629995167874,0.265808137741522,0.276377633552103,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50979,0.0165016366377589,0.002899859919563,0.0108179111954154,0.0221853620801024,1.2800612972638e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30740.Glucose,48571,-0.0192925907652354,0.00309031421322456,-0.0253496066231556,-0.0132355749073153,4.36627524335245e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50820,0.0201217749784136,0.00314003025956225,0.0139673156696715,0.0262762342871556,1.49785778274657e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30760.HDL cholesterol,48584,-0.0745854427727155,0.00340905974532628,-0.081267199873555,-0.067903685671876,4.36726453836555e-105
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30770.IGF-1,50835,-0.0366110025833222,0.00283111814929099,-0.0421599941559325,-0.0310620110107118,3.89710204299997e-38
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30780.LDL direct,50926,-0.00181676545187683,0.00283351680374441,-0.00737045838721588,0.00373692748346221,0.521417907482994
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30790.Lipoprotein A,45685,0.0139719674918599,0.00308991837223669,0.007915727482276,0.0200282075014438,6.16498852752693e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30810.Phosphate,48550,0.0178746001619028,0.00308575177957792,0.0118265266739301,0.0239226736498755,7.01566739270996e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30830.SHBG,48324,0.00604591368700825,0.00325134709467678,-0.00032672661855824,0.0124185539925747,0.0629671218517966
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30840.Total bilirubin,50885,-0.0151536242015428,0.00285123651228227,-0.0207420477656161,-0.00956520063746959,1.07665879522386e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30850.Testosterone,46453,-0.00301641175636363,0.00495224527753112,-0.0127228125003246,0.00668998898759737,0.542464559557146
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30860.Total protein,48589,0.01412117336156,0.00291634802684501,0.00840513122894373,0.0198372154941762,1.29285732457326e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30870.Triglycerides,50973,0.0507611150565522,0.0031382656796144,0.044610114324508,0.0569121157885964,1.44660073730227e-58
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30880.Urate,50946,0.106083337284386,0.00340222240952327,0.0994149813617204,0.112751693207052,1.20163716619413e-209
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30890.Vitamin D,49445,-0.0152565972321102,0.00309933817690471,-0.0213313000588434,-0.00918189440537699,8.59746691366988e-07
CD300E,CMRF35-like molecule 2,Physical measures,X3137.Number of measurements made,49866,0.0358515723038415,0.0318751427207317,-0.0266237074287927,0.0983268520364756,0.260705537067839
CD300E,CMRF35-like molecule 2,Physical measures,X3143.Ankle spacing width,40251,0.0194536464011883,0.00485928044889147,0.00992945672136097,0.0289778360810155,6.27237078664696e-05
CD300E,CMRF35-like molecule 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40250,-0.0101742193302675,0.00394323320164737,-0.0179029564054964,-0.0024454822550387,0.00988405849515356
CD300E,CMRF35-like molecule 2,Physical measures,X3146.Speed of sound through heel,40251,-0.0197970555890018,0.00379997810649368,-0.0272450126777294,-0.0123490985002742,1.91439329203378e-07
CD300E,CMRF35-like molecule 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40251,-0.0168698003934607,0.00384943410697826,-0.0244146912431381,-0.00932490954378336,1.1813033419086e-05
CD300E,CMRF35-like molecule 2,Physical measures,X3148.Heel bone mineral density (BMD),40249,-0.0169327134780513,0.00383959602110641,-0.0244583216794199,-0.00940710527668272,1.04041675195773e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X3526.Mother's age at death,40968,-0.00859379501426631,0.00368697360077925,-0.0158202632717937,-0.00136732675673897,0.0197730633280214
CD300E,CMRF35-like molecule 2,Health and medical history,X3581.Age at menopause (last menstrual period),40343,-0.0206453192653958,0.00366976656765093,-0.0278380617379916,-0.0134525767928,1.87779381318213e-08
CD300E,CMRF35-like molecule 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30202,0.00660741274624417,0.0059369163507935,-0.0050289433013111,0.0182437687937994,0.265782093603267
CD300E,CMRF35-like molecule 2,Physical measures,X4100.Ankle spacing width (left),33397,0.0119017706723334,0.00634617911130864,-0.00053674038583152,0.0243402817304984,0.0607670928506636
CD300E,CMRF35-like molecule 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33395,-0.0120494025690018,0.00518810876826786,-0.0222180957548068,-0.00188070938319678,0.020228152401824
CD300E,CMRF35-like molecule 2,Physical measures,X4103.Speed of sound through heel (left),33397,-0.0227109773271793,0.00505810661850966,-0.0326248662994582,-0.0127970883549004,7.21100397592207e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33397,-0.0193802447656121,0.0051004247258922,-0.0293770772283608,-0.00938341230286343,0.000145813332018982
CD300E,CMRF35-like molecule 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33395,-0.019188320365639,0.00508619502427101,-0.0291572626132102,-0.00921937811806785,0.000162579956456377
CD300E,CMRF35-like molecule 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33397,-0.0193753928681323,0.005100136630573,-0.0293716606640554,-0.00937912507220922,0.000146246676269646
CD300E,CMRF35-like molecule 2,Physical measures,X4119.Ankle spacing width (right),33402,0.0110423192313597,0.0062609912725731,-0.00122922366288362,0.0233138621256029,0.0778217560178108
CD300E,CMRF35-like molecule 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33402,-0.01172977812715,0.00519238232113637,-0.0219068474765773,-0.00155270877772275,0.0239051090011255
CD300E,CMRF35-like molecule 2,Physical measures,X4122.Speed of sound through heel (right),33402,-0.0243943492731875,0.00507902245879635,-0.0343492332924283,-0.0144394652539466,1.58874225129258e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33402,-0.0203686946516555,0.00511410396026982,-0.0303923384137844,-0.0103450508895267,6.86337747929513e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33399,-0.0201496455134216,0.00510371239931657,-0.030152921816082,-0.0101463692107611,7.93983552020398e-05
CD300E,CMRF35-like molecule 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33402,-0.0203656150882794,0.0051141189260789,-0.030389288183394,-0.0103419419931648,6.88110076459157e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4194.Pulse rate,33661,0.020340309681378,0.00495316133472342,0.0106321134653201,0.0300485058974359,4.05117908227946e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4195.Pulse wave reflection index,33661,-0.00224370357596227,0.00497130992131259,-0.011987471021735,0.00750006386981041,0.6517620248609
CD300E,CMRF35-like molecule 2,Physical measures,X4196.Pulse wave peak to peak time,33658,-0.00729946623544278,0.00453008760966598,-0.0161784379503881,0.00157950547950254,0.10714208851116
CD300E,CMRF35-like molecule 2,Physical measures,X4198.Position of the pulse wave peak,33661,0.00280678043964441,0.00438504732759859,-0.00578791232244883,0.0114014732017377,0.522136611788073
CD300E,CMRF35-like molecule 2,Physical measures,X4199.Position of pulse wave notch,33661,0.0136734272456268,0.00488514577230673,0.00409854153190565,0.023248312959348,0.00513708751160355
CD300E,CMRF35-like molecule 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33661,0.00573471551289063,0.00438105640596043,-0.00285215504279182,0.0143215860685731,0.190573764291391
CD300E,CMRF35-like molecule 2,Physical measures,X4269.Number of triplets attempted (left),33560,-0.0263064087911629,0.136126650536607,-0.293114643842912,0.240501826260586,0.846767880180637
CD300E,CMRF35-like molecule 2,Physical measures,X4270.Volume level set by participant (left),33471,0.0558857348542471,0.0436220396044156,-0.0296134627704074,0.141384932478902,0.20017909681298
CD300E,CMRF35-like molecule 2,Physical measures,X4276.Number of triplets attempted (right),33562,-0.198597924870368,0.128591591276017,-0.450637443771361,0.0534415940306245,0.122524227160631
CD300E,CMRF35-like molecule 2,Physical measures,X4277.Volume level set by participant (right),33455,0.0648251498650756,0.0437973202658582,-0.0210175978560064,0.150667897586158,0.138877079451824
CD300E,CMRF35-like molecule 2,Cognitive function,X4288.Time to answer,33736,-0.0041422252836211,0.00555152979409381,-0.015023223680045,0.00673877311280277,0.455600995753717
CD300E,CMRF35-like molecule 2,Cognitive function,X4290.Duration screen displayed,33736,0.011558217065309,0.00494729857356082,0.00186151186112983,0.0212549222694883,0.0194984255911392
CD300E,CMRF35-like molecule 2,Physical measures,X46.Hand grip strength (left),52195,-0.0629355459699746,0.00408392196951618,-0.0709400330302263,-0.0549310589097229,2.31367981075822e-53
CD300E,CMRF35-like molecule 2,Physical measures,X47.Hand grip strength (right),52201,-0.0612657225041898,0.00407265144143235,-0.0692481193293972,-0.0532833256789824,6.07818619735494e-51
CD300E,CMRF35-like molecule 2,Physical measures,X48.Waist circumference,52288,0.0519628874172161,0.00546562000347599,0.0412502722104032,0.0626755026240291,2.11028227730307e-21
CD300E,CMRF35-like molecule 2,Health and medical history,X4803.Tinnitus,33569,0.13277562897027,0.0524436928953795,0.0299859908953258,0.235565267045213,0.0113653385752717
CD300E,CMRF35-like molecule 2,Working and living environment,X4825.Noisy workplace,33708,0.232237422163301,0.0739114507948556,0.0873709786053843,0.377103865721218,0.00168268008627637
CD300E,CMRF35-like molecule 2,Working and living environment,X4836.Loud music exposure frequency,33651,0.163626115957352,0.0878937688632267,-0.00864567101457175,0.335897902929277,0.062686432900579
CD300E,CMRF35-like molecule 2,Physical measures,X49.Hip circumference,52285,0.0204104181547038,0.0046374537140013,0.0113210088752612,0.0294998274341463,1.08047898179399e-05
CD300E,CMRF35-like molecule 2,Physical measures,X50.Standing height,52283,0.016939958058141,0.00379846149074759,0.00949497353627569,0.0243849425800063,8.23994826792006e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X5057.Number of older siblings,32636,0.00298497450902322,0.0461797109782929,-0.0875272590084309,0.0934972080264773,0.948463628764438
CD300E,CMRF35-like molecule 2,Physical measures,X51.Seated height,52155,0.00753768076048367,0.00381212600922368,6.59137824052603e-05,0.0150094477385621,0.0480186935350302
CD300E,CMRF35-like molecule 2,Eye measures,X5181.Ever had eye surgery,30689,0.160828182061941,0.103960817946244,-0.0429350211126968,0.364591385236579,0.121912149815493
CD300E,CMRF35-like molecule 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30671,0.00181774546276448,0.00567066724597675,-0.00929676233934995,0.0129322532648789,0.748560455813446
CD300E,CMRF35-like molecule 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30673,0.00528462628898123,0.00561357343242736,-0.00571797763857639,0.0162872302165389,0.346535713480791
CD300E,CMRF35-like molecule 2,Eye measures,X5190.Duration at which refractometer first shown (right),30599,0.00390386095431224,0.00564436647448411,-0.00715909733567661,0.0149668192443011,0.489190521541905
CD300E,CMRF35-like molecule 2,Eye measures,X5193.Duration at which refractometer first shown (left),30600,0.0027468508495823,0.00567110705271023,-0.00836851897372976,0.0138622206728944,0.628148475999259
CD300E,CMRF35-like molecule 2,Eye measures,"X5199.logMAR, initial (right)",30652,0.0383957941808747,0.0560805443829369,-0.0715220728096817,0.148313661171431,0.493587596058971
CD300E,CMRF35-like molecule 2,Eye measures,X5200.Final number of letters displayed (right),30652,0.337063176594825,0.414495402107142,-0.475347811535174,1.14947416472482,0.416140837185225
CD300E,CMRF35-like molecule 2,Eye measures,"X5201.logMAR, final (right)",30601,0.00543682666769768,0.00593308070430165,-0.00619201151273356,0.0170656648481289,0.359515030911819
CD300E,CMRF35-like molecule 2,Eye measures,X5202.Number of rounds to result (right),30652,-0.00677426519309557,0.0523068403725265,-0.109295672323248,0.0957471419370564,0.896958226077812
CD300E,CMRF35-like molecule 2,Eye measures,"X5206.logMAR, initial (left)",30651,0.0147449394474193,0.0557203950445651,-0.0944670348399283,0.123956913734767,0.791308127477462
CD300E,CMRF35-like molecule 2,Eye measures,X5207.Final number of letters displayed (left),30651,0.115163711677562,0.340583392994771,-0.552379738592188,0.782707161947313,0.735271702207831
CD300E,CMRF35-like molecule 2,Eye measures,"X5208.logMAR, final (left)",30587,0.00591984196048326,0.00584955515778839,-0.00554528614878198,0.0173849700697485,0.311570432437314
CD300E,CMRF35-like molecule 2,Eye measures,X5209.Number of rounds to result (left),30649,0.000214340821939647,0.0525662043990492,-0.102815419800197,0.103244101444076,0.996746733967831
CD300E,CMRF35-like molecule 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30354,-0.0203646414244728,0.00579594960101519,-0.0317247026424625,-0.00900458020648299,0.000445393121482861
CD300E,CMRF35-like molecule 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30354,-0.0229195418017941,0.00583127218948559,-0.0343488352931858,-0.0114902483104023,8.5755533934863e-05
CD300E,CMRF35-like molecule 2,Eye measures,X5256.Corneal hysteresis (right),30354,0.00155903819556292,0.00580407072465114,-0.00981694042475332,0.0129350168158791,0.788238308252259
CD300E,CMRF35-like molecule 2,Eye measures,X5257.Corneal resistance factor (right),30354,-0.0111240903464251,0.00580452422810165,-0.0225009578335043,0.000252777140654118,0.0553558687433017
CD300E,CMRF35-like molecule 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30352,-0.0197314914288003,0.00577841346869491,-0.0310571818274424,-0.00840580103015832,0.000642849019986133
CD300E,CMRF35-like molecule 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30352,-0.0187830364790887,0.00574036184161193,-0.0300341456886481,-0.00753192726952936,0.00107365825930278
CD300E,CMRF35-like molecule 2,Eye measures,X5264.Corneal hysteresis (left),30352,0.00373971572349571,0.00590026465444536,-0.00782480299921719,0.0153042344462086,0.526221765717619
CD300E,CMRF35-like molecule 2,Eye measures,X5265.Corneal resistance factor (left),30352,-0.00747982789394037,0.00582114986451347,-0.0188892816283868,0.00392962584050604,0.198863717857408
CD300E,CMRF35-like molecule 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29941,-0.0555842200118589,0.252760091800202,-0.550993999940256,0.439825559916538,0.825950203009861
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52194,0.054813897045841,0.0159943104577463,0.0234650485486583,0.0861627455430238,0.000610977818262987
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52194,0.0308602181025449,0.0164323870847766,-0.00134726058361721,0.0630676967887071,0.0603900209829405
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52194,0.00431802824485441,0.0421374215451859,-0.0782713179837099,0.0869073744734187,0.918380472003811
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52194,-0.00616471027486128,0.00696335154965659,-0.0198128793121882,0.00748345876246563,0.375998252917457
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52194,-0.00415078450731496,0.00636346881869779,-0.0166231833919626,0.00832161437733272,0.514223828836383
CD300E,CMRF35-like molecule 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37303,-0.00637688851196086,0.00803042245288758,-0.0221165165196205,0.00936273949569879,0.427156951694441
CD300E,CMRF35-like molecule 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37303,-0.0315483240664662,0.0199868503545804,-0.0707225507614438,0.00762590262851141,0.114485958548253
CD300E,CMRF35-like molecule 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37303,-0.00645442918374896,0.0156800099580508,-0.0371872487015285,0.0242783903340306,0.680614386576422
CD300E,CMRF35-like molecule 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37303,0.0237290907416794,0.00964656326309776,0.00482182674600777,0.042636354737351,0.0139126102211566
CD300E,CMRF35-like molecule 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52280,0.0255595736294932,0.013135355063253,-0.00018572229448267,0.0513048695534691,0.0516815061929303
CD300E,CMRF35-like molecule 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52280,0.0255595736294932,0.013135355063253,-0.00018572229448267,0.0513048695534691,0.0516815061929303
CD300E,CMRF35-like molecule 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52280,-0.00484003669882323,0.0104907577589181,-0.0254019219063027,0.0157218485086562,0.64454253513893
CD300E,CMRF35-like molecule 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52280,-0.0231121268552712,0.0163971481024647,-0.055250537136102,0.00902628342555966,0.158692302552063
CD300E,CMRF35-like molecule 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52280,0.0458293207729853,0.04150178830253,-0.0355141842999735,0.127172825845944,0.269484107101914
CD300E,CMRF35-like molecule 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52280,0.045774542456775,0.0279692682116528,-0.00904522323806449,0.100594308151614,0.101725098780998
CD300E,CMRF35-like molecule 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52280,0.040816288616683,0.04560219965613,-0.0485640227093318,0.130196599942698,0.370767635154362
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52194,0.0164914523773773,0.00843877895956331,-4.85543833668271e-05,0.0330314591381214,0.0506821307352333
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52194,0.025445986882477,0.0140804017334916,-0.00215160051516661,0.0530435742801206,0.0707432040050843
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52194,0.0127663455337821,0.00746574841566696,-0.00186652136092512,0.0273992124284894,0.087279142009491
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52194,0.0685683786815914,0.0138605467481665,0.0414017070551851,0.0957350503079977,7.57993795858808e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52194,0.0307643193432793,0.0134803376876431,0.00434285747549871,0.0571857812110598,0.0224872917483066
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52194,0.0786303399624455,0.00755982021787443,0.0638130923354117,0.0934475875894794,2.72842164164549e-25
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31885,0.148489693524302,0.0310537529285747,0.0876243377842959,0.209355049264309,1.77164475596818e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31885,0.0508939140596224,0.020419042319484,0.0108725911134337,0.0909152370058111,0.0127072984660589
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31885,0.154640445736164,0.0261266582160705,0.103432195632666,0.205848695839662,3.38552397743619e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31885,-0.0493658751128059,0.0233352263995548,-0.0951029188559332,-0.00362883136967854,0.0344197841047158
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52190,0.0594334152929583,0.0205279524373607,0.0191986285157314,0.0996682020701853,0.0037916042080414
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52190,0.0758154382512154,0.0353716254527436,0.00648705236383793,0.145143824138593,0.0320898989932353
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52190,0.258600266510804,0.0560702256196043,0.148702624296379,0.368497908725228,4.00442001205846e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52190,-0.00305572734889189,0.0547802802892021,-0.110425076715728,0.104313622017944,0.955516257979848
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52190,0.0316430222126204,0.0171529792060888,-0.00197681703131368,0.0652628614565545,0.0650840267243261
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52190,7.13789384381695e-05,0.0244970325169879,-0.0479428047948582,0.0480855626717345,0.997675164981134
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52190,0.0262411303612099,0.0121627402053138,0.00240215955879473,0.050080101163625,0.0309751683088741
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33985,0.151805876103288,0.0185352658914921,0.115476754955964,0.188134997250613,2.94534691325209e-16
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33985,0.111592811470811,0.0217070407386545,0.0690470116230485,0.154138611318574,2.7891328337115e-07
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33985,0.0971325612351909,0.028065388426987,0.0421243999182964,0.152140722552085,0.000540655886424792
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33985,0.0157610396250114,0.00972913727465831,-0.0033080694333189,0.0348301486833417,0.105268946797349
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37578,0.0285097904917716,0.00997516636538569,0.00895846441561565,0.0480611165679275,0.00426888027442263
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37578,-0.0585385078351664,0.00869054550513544,-0.0755719770252319,-0.0415050386451009,1.69726093773767e-11
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37578,0.016703934093108,0.00816529820848549,0.000699949604476485,0.0327079185817396,0.0408035713999833
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37578,0.0206501022097185,0.0196450563585874,-0.0178542082531127,0.0591544126725498,0.293204350954119
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37578,0.0516475223484687,0.0117461586405902,0.0286250514129119,0.0746699932840255,1.10635253953848e-05
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37578,-0.0178676537029479,0.0136651419583533,-0.0446513319413204,0.00891602453542465,0.191053919965868
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52194,-0.0569216892952472,0.018368446765345,-0.0929238449553234,-0.0209195336351711,0.00194445119748293
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52194,-0.0236559442625639,0.0118045059682027,-0.0467927759602413,-0.000519112564886577,0.0450823569838103
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52194,0.0233008609070628,0.0462421534770661,-0.0673337599079867,0.113935481722112,0.614344165874863
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52194,-0.0139129391466395,0.0116258490879895,-0.0366996033590988,0.00887372506581991,0.231424157261177
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52194,-0.0607787956918916,0.0139764510906036,-0.0881726398294746,-0.0333849515543087,1.3746147654879e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52194,0.0956114989567461,0.0156663493709678,0.0649054541896492,0.126317543723843,1.05483913246214e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52194,0.0251807252940481,0.00556083046578302,0.0142814975811134,0.0360799530069828,5.97268746214986e-06
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28838,0.0679927176755188,0.019371014263053,0.0300255297199349,0.105959905631103,0.000452571011725382
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28838,0.061812286426786,0.0255153420002509,0.0118022161062944,0.111822356747278,0.0154520891763896
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28838,-0.0707234281146615,0.0169440707228574,-0.103933806731462,-0.0375130494978611,3.05186693762314e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28838,0.0126682563125263,0.0153808656356764,-0.0174782403333995,0.042814752958452,0.410190386003455
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52321,0.00806496740613519,0.00634431017857713,-0.00436988054387597,0.0204998153561464,0.203663614231046
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52321,-0.00320348398033199,0.0169895975578823,-0.0365030951937813,0.0300961272331174,0.850442497374392
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52321,0.016383647263239,0.00619924089252038,0.00423313511389903,0.0285341594125789,0.00822580614731447
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52321,0.0185366099329251,0.0061788732744407,0.00642601831502128,0.0306472015508288,0.00270219618435023
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52321,0.0278422349209051,0.00891460843947918,0.0103696023795259,0.0453148674622843,0.00179070481442431
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52321,0.0133824881830434,0.00790430418024723,-0.00210994801024118,0.028874924376328,0.0904545745721097
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52321,0.0183812863506817,0.00662829626139861,0.00538982567834045,0.031372747023023,0.00555527289886017
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52321,0.218868305859189,0.0179917902888761,0.183604396892992,0.254132214825386,5.82941932160197e-34
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43619,-0.0451751339854098,0.00650523110621539,-0.0579253869535919,-0.0324248810172276,3.92157839994187e-12
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43619,0.00832214483221169,0.00721927520229252,-0.00582763456428166,0.022471924228705,0.249020260255819
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43619,0.0302017163570933,0.00724048507784643,0.0160103656045143,0.0443930671096723,3.04295363061108e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43619,-0.0229593890280281,0.0092597885785421,-0.0411085746419706,-0.00481020341408559,0.013166225709115
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43619,-0.0052616946074965,0.00656033733504646,-0.0181199557841876,0.00759656656919457,0.422536091572897
CD300E,CMRF35-like molecule 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52070,0.000322851402669275,0.00669871468315119,-0.0128066293763071,0.0134523321816456,0.961560368698585
CD300E,CMRF35-like molecule 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52070,-0.0239883475927846,0.00538035390995529,-0.034533841256297,-0.0134428539292723,8.28572249926148e-06
CD300E,CMRF35-like molecule 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52070,-0.00567148310574849,0.00588758711366972,-0.0172111538485411,0.00586818763704415,0.335407946324353
CD300E,CMRF35-like molecule 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52070,-0.0592734981851481,0.0129326427524153,-0.0846214779798821,-0.0339255183904141,4.59813497418543e-06
CD300E,CMRF35-like molecule 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52082,-0.0542578495398858,0.00606928435917103,-0.0661536468838611,-0.0423620521959106,4.13826899911752e-19
CD300E,CMRF35-like molecule 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52082,-0.0631453053866602,0.0109104661304666,-0.0845298190023748,-0.0417607917709456,7.21745738113567e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52194,-0.0624635581147702,0.00580672254752218,-0.0738447343079137,-0.0510823819216268,6.20071013303523e-27
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52194,-0.0607284797220925,0.00659020904708946,-0.0736452894543878,-0.0478116699897971,3.3277741838986e-20
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52194,0.0112963807684617,0.00862361600671703,-0.00560590660470368,0.0281986681416271,0.190228502234904
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52194,-0.0448427934706665,0.0124215097781905,-0.06918895263592,-0.0204966343054131,0.000306627427717427
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52194,0.0281860634728221,0.0128463339452311,0.00300724894016912,0.0533648780054751,0.0282369197242814
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52194,-0.0762133615800449,0.016615031269938,-0.108778822869123,-0.0436479002909663,4.51597790358183e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40251,-0.0168681789024161,0.00384942504799822,-0.0244130519964926,-0.00932330580833961,1.18353136630575e-05
CD300E,CMRF35-like molecule 2,Physical activities,X864.Number of days or week walked 10+ minutes,51681,-0.113805992212113,0.0253880541738612,-0.163566578392881,-0.0640454060313451,7.40191875165854e-06
CD300E,CMRF35-like molecule 2,Physical activities,X874.Duration of walks,47593,-0.005714694403276,0.00294603496580343,-0.0114889229362507,5.95341296987283e-05,0.0524171353655737
CD300E,CMRF35-like molecule 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50600,-0.153941173700749,0.0248708872247615,-0.202688112661282,-0.105194234740217,6.12080109834555e-10
CD300E,CMRF35-like molecule 2,Physical activities,X894.Duration of moderate activity,44385,-0.0520431498180438,0.0306403160840133,-0.11209816934271,0.00801186970662217,0.0894255136282373
CD300E,CMRF35-like molecule 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30489,-0.0206382480300244,0.00598073529145354,-0.0323604892012734,-0.00891600685877551,0.000562781131930524
CD300E,CMRF35-like molecule 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50589,-0.261322410334277,0.025822838432674,-0.311935173662318,-0.210709647006236,4.99726877799209e-24
CD300E,CMRF35-like molecule 2,Physical activities,X914.Duration of vigorous activity,38215,-0.00389045982152105,0.0038264082219447,-0.0113902199365327,0.00360930029349057,0.309295312093221
